Advertisement

Literatur

  • Ingomar-Werner Franz
Chapter
  • 12 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Ablad B, Börjessen E, Carlsson E, Johnsson G (1975) Effects of metoprolol and propranolol on some metabolic responses to catecholamines in the anesthetized dogs. Acta Pharmocol et Toxicol 36, Suppl V, 85Google Scholar
  2. 2.
    Ääiynen M, Mäkelä M, Hämeenaho P, Mattila MJ (1981) Prazosin enhances the antihypertensive effects of beta-blockers during isometric and dynamic exercise. Am Clin Research 132: 71Google Scholar
  3. 3.
    Ahlborg G, Feiig P, Hagenfeldt L, Hendler R, Wahren J (1974) Substrate turnover during prolonged exercise in man: splanchnic and leg metabolism of glucose, free fatty acids and amino acids. J Clin Invest 53: 1080PubMedGoogle Scholar
  4. 4.
    Ahlborg G, Felig P (1976) Influence of glucose ingestion on fuel-hormone response during prolonged exercise. J Appl Physiol 41: 683PubMedGoogle Scholar
  5. 5.
    Ahlborg G and Felig P (1977) Substrate utilization during prolonged exercise preceded by ingestion of glucose. Am J Physiol 233 (Endocrinol Metab Gastrointest Physiol 2): El 88Google Scholar
  6. 6.
    Ahlborg G, Felig P (1982) Lactate and glucose exchange across the forearm, legs and splanchnic bed during and after prolonged leg exercise. J Clin Invest 65: 45Google Scholar
  7. 7.
    Ahlquist RP (1967) Development of the concept of alpha and beta adrenotopic receptors. Am NY Acad Sci 139: 549Google Scholar
  8. 8.
    Aigner A, Muß N, Krempler F, Fenninger H, Sandhofer F (1983) Der Einfluß einer akuten ßr und Rezeptorenblockade auf den Kohlenhydrat- und Fettstoffwechsel unter Belastungsbedingungen. Dtsch Med Wschrl 58: 293Google Scholar
  9. 9.
    Ambrosioni F, Borghi C, Costa FU, Magnani B (1982) Cardiovascular effects induced in hypertensive patients by prizidilol during stress and exercise. Abstract Ninth Scientific meeting of the International Society of Hypertension. Mexico City, p 15Google Scholar
  10. 10.
    Ames RP, Hill P (1976) Increase in serum lipids during treatment of hypertension with chlortalidone. Lancet 1: 721PubMedGoogle Scholar
  11. 11.
    Anavekar SN, Louis WJ, Morgan TQ, Doyle AE, Johnston CI (1975) The relationship of plasma levels of pindolol in hypertensive patients to effects on blood pressure, plasma renin and plasma noradrenaline levels. Clin Exp Pharmacol Physiol 2: 203PubMedGoogle Scholar
  12. 12.
    Andersen M, Bechsgaard P, Fredriksen J, Hansen D, Jessen-Jürgensen H, Nielsen P, Pedersen F, Pedersen-Bjergaard O, Lind-Rasmussen S (1975) The effect of alprenolol on mortality among patients with definitive or suspected acute myocardial infarction. Lancet 2: 865Google Scholar
  13. 13.
    Anderson SD, Bye PTP, Perry CP, Hamor GP, Theobald G and Nyberg G (1979) Limitation of work performance in normal adult males in the presence of beta-adrenergic blockade. Aust NZ J Med 9: 515Google Scholar
  14. 14.
    Anschütz F (1970) Über die Zuverlässigkeit der auskultatorisch ermittelten Blutdruckwerte unter körperlicher Belastung. Fortschr Med 88: 1391Google Scholar
  15. 15.
    Anderson K, Vik-Mo H (1982) Role of Frank-Starling mechanism during maximal semisupine exercise after oral atenolol. Br Heart J 48: 149Google Scholar
  16. 16.
    Antonis A, Clark ML, Hodge RL, Molony M, Pilkington TR (1967) Receptor mechanismus in the hyperglycaemic response to adrenaline in man. Lancet 27: 1135Google Scholar
  17. 16a.
    Aoki K, Kondo S, Mochizuki A et al (1978) Antihypertensive effect of cardiovascular Ca22 +2-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade. Am Heart J 96: 218–226PubMedGoogle Scholar
  18. 17.
    Arnold A, McAuliff JP, Colella DF, O’Connor WV and Brown TG (1968) The ft-receptor mediated glycogenolytic responses to catecholamines in the dog. Arch Int Pharmacodyn 176: 451PubMedGoogle Scholar
  19. 18.
    Ashton WI (1976) An open, multicentre study of acebutolol in hypertension. Curr Med Res Opin 4: 442PubMedGoogle Scholar
  20. 19.
    Asknes EG (1977) β-Blocker: farlig for skilopere? Tiddskrift for den Norske Laegeforening 12: 576Google Scholar
  21. 20.
    Astra chemical GmbH (1979) Herzkreislaufinformation 1Google Scholar
  22. 21.
    Astrand J (1965) Blood pressure during physical work in a group of 221 women and men 48-63 years old. Acta Med Scand 178: 41PubMedGoogle Scholar
  23. 22.
    Astrand PO, Rodahl K (1977) Textbook of Work Physiology. McGraw-Hill, New YorkGoogle Scholar
  24. 23.
    Atterhög IH, Duner H, Pernow B (1977) Haemodynamic effects of pindolol in hypertensive patients. Acta Med Scand Suppl 606: 55PubMedGoogle Scholar
  25. 24.
    Bannister EW and Griffiths J (1972) Blood levels of adrenergic amines during exercise. J Appl Physiol 33: 674Google Scholar
  26. 25.
    Bachmann K (1969) Arbeitsbelastung und Hypertonie. In: Sasse H (Hrsg) Hypertonie, Pathogenese, Klinik und Therapie. Schattauer, Stuttgart New YorkGoogle Scholar
  27. 26.
    Bachmann K, Zerzawy R, Riess PJ, Zölch KA (1970) Blutdrucktelemetrie - kontinuierliche, direkte Blutdruckmessung im Alltag und beim Sport. Dtsch Med Wschr 95: 741PubMedGoogle Scholar
  28. 27.
    Baller D, Schenk H, Zipfel J, Hellige G (1979) Möglichkeiten und Grenzen von klinischn O2-Verbrauchsparametern. Z Kardiol 68: 656Google Scholar
  29. 28.
    Barath E (1928) Arterial Hypertension and physical work. Arch Intern Med 42: 296Google Scholar
  30. 29.
    Barwich D, Klett G, Eckert W, Weicker H (1980) Exercise-induced lipolysis with central Cushing’s disease. Int J Sports Med 1: 120Google Scholar
  31. 29a.
    Bechgaard P (1967) The natural history of benign hypertension - 1000 hypertensive patients followed from 26 to 32 years. In: Stamler J, Stamler R, Pullman TN (eds) The epidemiology of hypertension. Proceedings of an international symposium. Grune and Stratton, New York, p357Google Scholar
  32. 30.
    Beevers DG, Fairman MJ, Hamilton M, Harpur JE (1973) Antihypertensive treatment and the course of etablished cerebral vascular disease. Lancet 1: 1407PubMedGoogle Scholar
  33. 31.
    Behrenbeck DW, Tauchert M, Meurer KA, Nieheres B, Jansen W, Hötzel J, Hilger H (1977) Der myokardiale Sauerstoffverbrauch bei Patienten mit arterieller Hypertonie vor und nach Drucksenkung. Verh Dtsch Ges Kreisl Forsch 43: 111Google Scholar
  34. 32.
    Ben Ari E, Kellermann JJ, Lapitod C, Droiy Y, Fisman E, Hayat M (1978) Effect of prolonged intensive training on cardiorespiratory response in patiente with angina pectoris. Br Heart J40: 1143Google Scholar
  35. 33.
    Bengtsson E (1956) The working capacity in normal children evaluated by submaximal exercise on the bicycle ergometer compared with adults. Acta Med Scand 154: 91PubMedGoogle Scholar
  36. 34.
    Berger M, Berchtold P (1979) Beta-Rezeptorenblocker. Dtsch Med Wschr 24: 888Google Scholar
  37. 35.
    Berglund G, Wilhelmsen L, Sannerstedt R, Hansson L, Anderson O, Sivertsson R, Wikstrand J (1978) Decrease of CHD morbidity by treatment of hypertension. Lancet 1: 1PubMedGoogle Scholar
  38. 36.
    Berkowitz WD, Wit AL, Lan SH, Steiner C, Damato AN (1969) The effects of propranolol on cardial conduction. Circulation 21: 855Google Scholar
  39. 37.
    Berry CL (1978) Hypertension and arterial development - Longterm considerations. Br Heart J 40: 709PubMedGoogle Scholar
  40. 38.
    Bertel O, Kiowski W, Bühler FR (1979) Nieren- und Hochdruckkrankheiten 4: 156Google Scholar
  41. 39.
    Bethge K-P, Klein H, Lichtlen PR (1979) Koronare Herzerkrankung, Rhythmusstörungen und plötzlicher Herztod. Internistische Welt 4: 107Google Scholar
  42. 40.
    Beveârd S, Holmgren A, Jonsson (1960) The effect of body position on the circulation at rest and during exercise, with special reference to the influence on the stroke volume. Acta Physiol Scand 49: 279Google Scholar
  43. 41.
    Bielmann P, Leduc G (1979) Effects of metoprolol and propranolol on lipid metabolism. Int J Clin Pharmacol Biopharm 17: 378PubMedGoogle Scholar
  44. 42.
    Bielmann P, Leduc G, Germain M, Davignon J (1980) Betablockers and changes in lipoprotein fractions. New Eng J Med 302: 298PubMedGoogle Scholar
  45. 43.
    Bielmann P, Brun D, Gagné C, Moorjani SC, Jéquier J-C, Berhand M, Lupien P-J (1982) Beta- blockers and their effects on lipoproteins, phospholipids, apoproteins A und B, in whole plasma and the different fraction. Int J Clin pharmacol Ther Tox 20: 259Google Scholar
  46. 44.
    Birnbaum J, Di Bianco R, Becker KL, Costello RB, Suigh SN, Gottdiener JS, Fletcher RD (1983) Glucose and lipid metabolism during acebutolol and propranolol therapy of angina in nondiabetic patients. Clin Pharmacol Therap 33: 294Google Scholar
  47. 45.
    Birnbaumer L, Pohl SL, Kaumann AJ (1974) Receptors and aceptors: A necessary distinction in hormone bindung Studies. In: Greengard P, Robinson GA (Hrsg) Advances in cyclic mucleotide research. Vol 4, Raven Press, New York, S 239Google Scholar
  48. 46.
    Blümchen G, Esche H-H (1981) Belastungshämodynamik des linken Ventrikels unter chronischer Rezeptorenblocker-Therapie bei Herzinfarktpatienten mit geringer Angina-pectoris und guter Belastbarkeit. Z Kardiol 70: 678PubMedGoogle Scholar
  49. 47.
    Bodem R, Albig M, Barwich D (1978) Kardiale Befunde bei Patienten mit Akromegalie: Eine echokardiographische Studie. Z Kardiol 67: 163PubMedGoogle Scholar
  50. 48.
    Bodem G, Ochs HR (1979) Pharmakologie der β-Rezeptorenblocker. Dtsch med Wschr 104: 6PubMedGoogle Scholar
  51. 49.
    Borchard U (1983) Pharmacological properties of diastolol, the major metabolite of acebutolol 3rd International Bayer Beta Blocker Symposium, Rio de Janeiro, Abstracts, p 4Google Scholar
  52. 50.
    Boyer J, Kasch F (1970) Exercise therapy in hypertensive men. Am J Med Ass 211: 1668Google Scholar
  53. 51.
    Bradby GVH, Valente AJ, Walton KW (1978) Serum high density lipoproteins in peripheral vascular disease. Lancet II: 1271Google Scholar
  54. 52.
    Brecht HM, Banthien F, Ernst W, Schoeppe W (1976) Increased plasma noradrenaline concentrations in essential hypertension and their decrease after longterm treatment with a ß-reeeptorblocking agent ( Pindolol ). Clin Sci Mol Med 51: 485Google Scholar
  55. 53.
    Breckenridge A, Orme M, Dollary CT (1971) The effect of dopamine on renal blood flow in man. Eur J Clin Pharmacol 3: 131Google Scholar
  56. 54.
    Brest AN (1975) Therapeutic aspects of hypertension. Angiology 26: 584PubMedGoogle Scholar
  57. 55.
    Brick I, Glover WE, Hutchison KJ and Roddie IC (1966) Effects of propranolol on peripheral vessels in man. Am J Cardiol 18: 329PubMedGoogle Scholar
  58. 56.
    Brisma K (1981) Prolactin secretion in the empty sella snydrome in prolactinomas and in acromegalic. Acta Med Scand 209: 397Google Scholar
  59. 57.
    Brown ThG (1968) The ßx-Receptor mediated glycogenolytic responses to catecholamines in the dog. Arch Int Pharmacoclyn 176: 451Google Scholar
  60. 58.
    Bruce RA, Hossack KF, Kusumi F, Clarke L (1979) Acute effects of oral propranolol on hemodynamic responses to upright exercise. Am J Cardiol 44: 132PubMedGoogle Scholar
  61. 59.
    Bruhn R, Höffken I, Henry R, Lücker PW (1981) Zur Pharmakodynamik von Acebutolol. Therapiewoche 31: 5470Google Scholar
  62. 60.
    Buchanan N, Weir RJ (1982) A comparison of nifedipine and mefruside in the treatment of mild/moderate hypertension. Abstract Ninth Scientific Meeting of the International Society of Hypertension. Mexico City, p 59Google Scholar
  63. 61.
    Bucher HW, Stucki P (1969) The effect of various betareceptor blocking agents on platelet aggregation. Experienta 25: 280Google Scholar
  64. 62.
    Bühler FR, Bertel O, Kiowski DW (1978) Plasmanoradrenaline and adrenaline and β-adreno- receptor responsiveness in renin subgroups of essential hypertension. Clin Sci Mol Med 55: 57Google Scholar
  65. 63.
    Bühler FR, Kiowski W, Bolli P, Bertel O (1978) Das Potential der Beta-Blocker in der Hochdruckbehandlung. Internist 19: 510PubMedGoogle Scholar
  66. 64.
    Burkart F, Bühler FR, Pfisterer M, Küng M (1976) Belastungshämodynamik und Renin vor und nach akuter β-Blockade bei Patienten mit essentieller Hypertonie. Schweiz Med Wschr 106: 1732PubMedGoogle Scholar
  67. 65.
    Carlson LA, Ekelund L-G, Fröberg SO (1971) Concentration of triglycerides, phospholipids and glycogen in skeletal muscle and of free fatty acids and β-hydroxybutynic acid in blood in man in response to exercise. Eur J Clin Invest 1: 248PubMedGoogle Scholar
  68. 66.
    Carlsson E, Fellenius E, Lundberg P, Svensson L (1978) β-adrenoceptor blockers, plasma-po tassium and exercise. Lancet 2: 424Google Scholar
  69. 67.
    Carlström S (1969) Studies on fatty acid metabolism in diabetes during exercise. VII. Plasma glycerol concentrations in juvenile diabetics during exercise before and after adequate insulin treatment. Acta Med Scand 186: 429PubMedGoogle Scholar
  70. 68.
    Carlström S, Westling H (1970) Metabolic, circulatory and respiratory effects of a new sympathomimetic ß-receptor-stimulating agent, terbutaline, compared with those of orciprenaline. Acta Med Scand Suppl 512: 33PubMedGoogle Scholar
  71. 69.
    Carvalho AC, Colman RW, Lees RS (1974) Platelet function in hyperlipoproteinaemia. New Engl J Med 290: 434PubMedGoogle Scholar
  72. 70.
    Castelli WP, Doyle JT, Gordon T, Haines CG, Hjostland MC, Hulley SB, Kagan A, Zukel WJ (1977) HDL-Cholesterol and other lipids in coronary heart disease. Circulation 55: 767PubMedGoogle Scholar
  73. 71.
    Chodakowska J, Nazar K, Wocial B, Jarecki M, Skorka B (1975) Plasma catecholamines and renin activity in response to exercise in patients with essential hypertension. Clin Sci Mol Med 49: 511PubMedGoogle Scholar
  74. 72.
    Choquette E, Ferguson R (1973) Blood pressure reduction in boderline hypertensives following physical training. Canad Med Ass J108: 699Google Scholar
  75. 73.
    Christensen NJ, Brandsborg O (1973) The relationship between plasma catecholamine concentration and pulse rate during exercise and standing. Eur J Clin Invest 3: 199Google Scholar
  76. 74.
    Christensen NJ, Trap-Jensen J, Clausen JP, Noer J, Krogsgaard A, Larsen O (1975) Effect of beta-receptorblockade on heart rate hepatic blood flow and circulating noradrenaline during exercise in man. Acta Physiol Scand 95: 62Google Scholar
  77. 75.
    Christensen NJ, Galbo H, Hansen JF, Hesse B, Richter EA and Trap-Jensen J (1979) Catecholamines and exercise. Diabetes 28: Supplement 1: 58PubMedGoogle Scholar
  78. 76.
    Clausen JP, Trap-Jensen J, Lassen NA (1970) The effect of training on the heart rate during arm and leg exercise. Scand J Clin Lab Invest 26: 295PubMedGoogle Scholar
  79. 77.
    Clausen JP, Trap-Jensen J (1970) Effects of training on the distribution of cardiac output in patients with coronary artery disease. Circulation 42: 611PubMedGoogle Scholar
  80. 77a.
    Cohen A, Watkins J, Mitas J, Schwartzman M, Cohen JM, Warren SE, Vieweg WV (1981) Clinical correlates in hypertensive patients with left ventricular hypertrophy diagnosed with echocardiography. Amer J Cardiol 47: 335PubMedGoogle Scholar
  81. 78.
    Colemann AJ, Leary WP (1972) Cardiovascular effects of acebutolol in exercising man: A comparative study with practolol and propranolol. Curr Ther Res 14: 673Google Scholar
  82. 79.
    Conway N, Seymor J, Gelson A (1968) Cardial failure in patients with valval heart disease after use of propranolol to control atrial fibrillation. Br Med J 2: 213PubMedGoogle Scholar
  83. 79a.
    Corea L, Bentivoglio M, Verdecchia P, Prowidenza M, Motolese M (1984) Regression of left ventricular hypertrophy during metoprolol treatment. Int J Clin Pharmacol Ther Fox 22: 365Google Scholar
  84. 80.
    Costill DL, Fox EL (1969) Energetics of marathon running. Med Sci Sports 1: 81Google Scholar
  85. 81.
    Costill DL, Branam G, Eddy D, Sparks K (1971) Determinants of marathon running success. Int Z Angew Physiol 29: 249PubMedGoogle Scholar
  86. 82.
    Costill DL, Coyle F, Dalsky G, Evans W, Fink W, Hoopes D (1977) Effects of elevated plasma FFA and insulin on muscle glycogen usage during exercise. J Appl Physiol 43: 695PubMedGoogle Scholar
  87. 83.
    Courville C, Mason VR (1938) The heart in acromegalic. Arch Int Med 61: 704Google Scholar
  88. 84.
    Cruickshank JM (1980) The clinical importance of cardioselectivity an lipophilicity in beta blockers. Am Heart J100: 160Google Scholar
  89. 85.
    Cryer PE (1976) Isotrope derivative measurements of plasma norepinephrine and epinephrine in man. Diabetes 25: 1071PubMedGoogle Scholar
  90. 86.
    Csapo G, Weisswange A, Roskamm H (1978) Beta-Rezeptorenblocker bei atrioventrikulärem Block II. Grades. Intrakardiale elektrographische Untersuchungen an 9 Patienten. Z kardiol 67: 420PubMedGoogle Scholar
  91. 87.
    Cullinane E, Siconolfl S, Saritelli A, Thompson PD (1982) Acute decrease in serum triglycerides with exercise: is there threshold for an exercise effect? Metabolism 31: 844PubMedGoogle Scholar
  92. 88.
    Daskalopoulos N, Schmitt H (1975) Effect de l’acébutolol sur les structures cardiovasculaires centrales. Thérapie 30: 843–54PubMedGoogle Scholar
  93. 89.
    Davidson MB (1979) Effect of growth hormone administration to hypophysectomized rats on muscle lipid metabolism. Metabolism 28: 729–734PubMedGoogle Scholar
  94. 90.
    Day JL, Simpson N, Metcalfe J, Page RL (1979) Metabolic consequences of atenolol and propranolol in treatment of essential hypertension. Br Med J1: 77Google Scholar
  95. 91.
    Deacon SP, Barnett D (1976) Comparison of atenolol and propranolol during insulin-induced hypoglycaemia. Br Med J II: 272Google Scholar
  96. 92.
    De Gandpré R, Raab W (1953) Interrelated hormonal factors in cardiac hypertrophy; experiments in nonhypertensive hypophysectomized rats. Circulât Res 1: 345Google Scholar
  97. 93.
    Delius W, Wirtzfeld A, Dominiak P, Sebennig H, Blömer H, Grobecker H (1979) Effects of acute beta-adrenoceptor blockade on plasma norepinephrine concentration and hemodynamics in postmyocardial infarction patients. Z kardiol 68: 441–48PubMedGoogle Scholar
  98. 94.
    Detry JM, Rousseau M, Vandenbrouche G, Kusumi F, Brasseur LA, Bruce RA (1971) In creased arteriovenous oxygen difference after physical training in coronary heart disease. Circulation 44: 109PubMedGoogle Scholar
  99. 95.
    De Rose E, Romanowsky S, Rost R (1982) Die Auswirkungen unterschiedlicher Betarezeptoren-Blocker unter Ausdauerbelastung bei Gesunden und bei Diabetikern. Dtsch Z Sportmed 33: 222Google Scholar
  100. 96.
    Deutsche Liga zur Bekämpfung des hohen Blutdruckes (1976) Merkblatt, Empfehlungen zur BlutdruckmessungGoogle Scholar
  101. 96a.
    Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55: 613PubMedGoogle Scholar
  102. 96b.
    Devereux RB, Savage DD, Sachs I, Laragh JH (1980) Effect of blood pressure control on LV hypertrophy and function in hypertension (abstr). Circulation 62, Suppl II: 2Google Scholar
  103. 96c.
    Devereux RB, Savage DD, Drayer J, Caragh J (1982) Left ventricular hypertrophy and function in high, normal, and low-renin forms of essential hypertension. Hypertension 4: 524PubMedGoogle Scholar
  104. 96d.
    Devereux RB, Savage DD, Sachs I, Caragh J (1983) Relation of hemodynamic load to left ventricular hypertrophy and performance in hypertension. Amer J Cardiol 51: 173Google Scholar
  105. 97.
    Dick CB, Stone MC (1973) Prevalence of hyperlipoproteinemies in an random sample of men and in patients with ischemic heart disease. Br Heart J 35: 954PubMedGoogle Scholar
  106. 98.
    Diehm C, Mörl H, Schettler G (1983) Wirkungen von Propranolol und Metoprolol auf die periphere Durchblutung bei Claudicatio intermittens. Vasal2: 55Google Scholar
  107. 99.
    Dimsdale JE, Moss J (1980) Plasma catecholamines in stress and exercise. JAMA 243: 340PubMedGoogle Scholar
  108. 100.
    Distler A, Philipp Th (1976) Stellenwert der β-Rezeptorenblocker im Vergleich zu Diuretika in der Basistherapie der Hypertonie. Med Welt 26: 1022Google Scholar
  109. 101.
    Dole VP (1956) A relation between nonesterified fatty acids in plasma and the metabolism of glucose. J Clin Invest 35: 150PubMedGoogle Scholar
  110. 102.
    Dollery CT, Paterson W, Conolly ME (1969) Clinical pharmacology of beta-receptorblocking drugs. Clin Pharmacol Ther 1O: 765Google Scholar
  111. 103.
    Dominiak P, Kunkel G, Grobecker H (1980) Elevated plasma catecholamines in young hypertensive patients (Abstr). World Conference on Clinical Pharmacology and Therapeutics. London, p 506Google Scholar
  112. 104.
    Dorow P (1982) Effects of β-adrenoceptor blockade on carbohydrate metabolism during exercise. Comparison of pindolol and metoprolol. Br J Clin Pharmac 13:429 SGoogle Scholar
  113. 104a.
    Drayer JIM, Gardin JM, Weber MA, Aranow WS (1982) Cardiac muscle mass during vasodilation therapy of hypertension. Clin Pharmacol Ther 32: 283PubMedGoogle Scholar
  114. 104b.
    Drayer JIM, Gardin JM, Weber MA, Aranow WS (1982) Increases and decreases in ventricular septal thickness during diuretic therapy. Clin Pharmacol Ther 32: 283PubMedGoogle Scholar
  115. 105.
    Drews A (1967) Bedeutung und Ergebnisse ergometrischer Leistungskontrollen bei aktiver Bewegungstherapie. Arbeitsmed, Sozialmed, Arbeitshyg 2: 441Google Scholar
  116. 106.
    Dufey K, Krönig B (1974) Kritischer Belastungsblutdruck bei Hochdruckkranken. Ergebnisse direkter Blutdruckmessung unter alltäglichen und fahrradergometrischen Belastungen, Schlußfolgerungen für die Praxis. Fortschr Med 92: 1339PubMedGoogle Scholar
  117. 107.
    Dunn FG, Melville DI, Jones JV, Wrimer AR, Cawrie TDV (1973) Standardized stress and hypertension: comparison of effect of propranolol and methyldopa. Br J Clin Pharmac 5: 223Google Scholar
  118. 107a.
    Dunn FG, Chandraratna P, de Carweko J, Basta L, Fröhlich E (1977) Pathophysiologic assessment of hypertensive disease with echocardiography. Amer J Cardiol 39: 789PubMedGoogle Scholar
  119. 108.
    Dunn FG, Cornier AR, Cawrie TDV (1979) Objective measurement of performance during acute stress in patients with essential hypertension: assessment of the effects of propranolol and metoprolol. Clin Sci 57: 413SGoogle Scholar
  120. 109.
    Eaton RP, Schade DS (1978) Modulation and implications of the counterregulatory hormones: glucagon, catecholamines, Cortisol and growth hormone. In: Katzen HM, Mahler RJ (eds) Diabetes, Obesity and Vascular Disease. Halstead, New York, pp 341–372Google Scholar
  121. 110.
    Editoral (1977) Beta blockers for diabetics. Lancet 1: 843Google Scholar
  122. 111.
    Editoral (1980) Fatigue as an unwanted effect of drugs. Lancet 1: 1285–1286Google Scholar
  123. 112.
    Ekblom B, Goldberg AN, Kilbom A and Astrand P-0 (1972) Effects of atropine and propranolol on the oxygen transport system during exercise in man. Scand J Clin Invest 30: 35PubMedGoogle Scholar
  124. 113.
    Ekelund LG, Ekelung C, Rössner S (1982) Antihypertensive effects at rest and during exercise of calcium blocker, nifedipine alone and in combination with metoprolol. Acta Med Scand 212: 71–75PubMedGoogle Scholar
  125. 114.
    Eliasson K, Ajemdahl P, Hylander B, Kahan T, Lins L-E (1982) Circulatory and sympathoadrenal responses after long-term beta-blockade. Abstract Ninth Scientific Meeting of the International Society of Hypertension. Mexico CityGoogle Scholar
  126. 115.
    Empfehlungen zur indirekten Messung des Blutdruckes beim Menschen. Kommission der Deutschen Gesellschaft für Kreislaufforschung (1971). Z KreislaufforschgóO: 1Google Scholar
  127. 116.
    Engel FE and White JE (1960) Some hormonal influences on fat mobilization from adipose tissue. Am J Clin Nutr 8: 961Google Scholar
  128. 117.
    England JDF, Simons CA, Gibson JC (1980) The effect of metoprolol and atenolol on plasma high density lipoprotein levels in man. Clin Exp Pharm Physiol 7: 329Google Scholar
  129. 118.
    Ensinck JW, Williams RH (1974) Disorders causing hypoglycemia. In: Williams RH (Hrsg) Textbook of endocrinology S. 627, Saunders, PhiladelphiaGoogle Scholar
  130. 119.
    Epstein CC (1948) Extreme cardiac enlargement. Ann Int Med 48: 1387Google Scholar
  131. 120.
    Epstein SE, Robinson BF, Kahler RL, Braunwald E (1965) Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man. J Clin Invest 44: 1745PubMedGoogle Scholar
  132. 121.
    Erikssen J, Jervell J (1975) A trial of a new adrenergic β-blocker, ICI66082, in the treatment of hypertension. Acta Med Scand 198: 49PubMedGoogle Scholar
  133. 122.
    Eriksson BO, Persson B, Thoreil JI (1971) The effects of repeated prolonged exercise on plasma growth hormone, insuline, glucose, lactate and ß-hydroxybutynic acid in 13-years old boys and in adults. Acta Paediatr Scand (suppl) 217: 142Google Scholar
  134. 123.
    Escher M, Heyden S, Christeller S, Gasser JP, Keller H, Ramsler L, Gsell O (1974) Hypertonie, Nikotinabusus, Hypercholesterinämie und Übergewicht bei Schweizer Männern 1973. Schweiz Med Wschr 104: 1423PubMedGoogle Scholar
  135. 124.
    Esler M, Leonhard P, Jackman G, Jennings G, Korner P (1982) Plasma noradrenaline measurements are a failible index of Sympathie nervous system activity in humans. Abstract Ninth Scientific Meeting of the International Society of Hypertension. Mexico City, p 109Google Scholar
  136. 125.
    Fain JN, Kovacev VP, Scow RO (1965) Effect of growth hormone and dexamethasone on lipolysis and metabolism in isolated fatt cells of the rat. J Biol Chem 240: 3522PubMedGoogle Scholar
  137. 126.
    Falkner B, Qiesti G, Affrime MB, Lowenthal DT (1982) The effect of a centralacting agent versus diuretics on the cardiovascular response to mental stress in adolescent hypertension. Abstract Ninth Scientific meeting of the International Society of Hypertension. Mexico City, pillGoogle Scholar
  138. 127.
    Fehm HL, Voigt KH, Pfeiffer EF (1972) Problems and artefacts in ACTH assay. Horm Metab Res 4: 477PubMedGoogle Scholar
  139. 127a.
    Feigenbaum H (1981) Echocardiography. Lea u. Febinger, Philadelphia, 132Google Scholar
  140. 128.
    Feigl EO (1967) Sympathie control of the coronary circulation. Circ Res 20: 262PubMedGoogle Scholar
  141. 129.
    Felig P, Wahren J (1975) Fuel homeostasis in exercise. N Engl J Med 21: 1078–1084Google Scholar
  142. 130.
    Felig P, Cherif A, Minagawa A, Wahren J (1982) Hypoglycemia during prolonged exercise in normal men. N Engl J Med 306: 895PubMedGoogle Scholar
  143. 131.
    Fellenius E, Hedberg R, Karlsson N (1980) The effect of β-receptor blockade on adrenaline- induced changes in m. vastus lateralis and m.soleus of the rat in vivo. Acta Physiol Scand 110: 259PubMedGoogle Scholar
  144. 132.
    Fellenius E (1983) Muscle fatique and β-blockers. - A review. Int J Sports Med 4: 1PubMedGoogle Scholar
  145. 133.
    Floras JS, Fox P, Hassan MO, Jones JK, Sleight P, Turner KL (1979) Assessment of the antihypertensive effect of atenolol with 24 h ambulatory monitoring of blood pressure. Clin Science 57: 3875Google Scholar
  146. 134.
    Floras JS, Hassan MO, Sever PS, Jones JV, Osikowska B, Sleight P (1981) Cuff and ambulatory blood pressure in subjects with essential hypertension. Lancet II: 107Google Scholar
  147. 135.
    Folgering H (1980) Central β-adrenergic effects on the control of ventilation in cats. Respiration 39: 131PubMedGoogle Scholar
  148. 136.
    Folgering A, van Bussel M (1980) Maximal exercise power after a single dose of metoprolol and of slow-release metoprolol. Eur J Clin Pharmacol 18: 225PubMedGoogle Scholar
  149. 137.
    Folkow B (1975) Vascular changes in hypertension - review and recent animal studies. In: Berglund G, Hansson L, Werkö L (Hrsg) Pathophysiology and management of arterial hypertension, Mölndal/SchwedenGoogle Scholar
  150. 138.
    Foster C, Costill DL and Fink WJ (1979) Effects of preexercise feedings on endurance performance. Med Sci Sports 11: 1PubMedGoogle Scholar
  151. 138a.
    Fouad FM, Nakashima Y, Tarazi RC, Salcedo EE (1982) Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa. Amer J Cardiol 49: 795PubMedGoogle Scholar
  152. 139.
    Friedewald WT, Levy RJ, Fredrickson DS (1972) Estimation of serum low density lipoprotein cholesterol concentration without the use of the preparative ultracentrifuge. Clin Chem 18: 499PubMedGoogle Scholar
  153. 140.
    Franz I-W, Lohmann FW (1977) Ergometrische Untersuchungen zur zusätzlichen Beurteilung der antihypertensiven Therapie. Verh Dtsch Ges Inn Med 83: 325PubMedGoogle Scholar
  154. 141.
    Franz I-W, Mellerowicz H (1977) Vergleichende Untersuchungen der PWC170 mit Leistungsstufen von unterschiedlicher Größe und Dauer. Z Kardiol 66: 670PubMedGoogle Scholar
  155. 142.
    Franz I-W (1978) Therapie der hypertonen Kreislaufregulationsstörungen bzw. Hypertonie durch dosiertes Training. Schw Z Sportmed 3: 117Google Scholar
  156. 143.
    Franz I-W, Lohmann FW, Koch G, Röcker L (1978) Der Einfluß sog. kardioselektiver und nichtkardioselektiver β-Rezeptorenblocker auf den Stoffwechsel während ergometrischer Leistung bei Hypertoniepatienten. Verh Dtsch Ges Inn Med 84: 813PubMedGoogle Scholar
  157. 144.
    Franz I-W, Lohmann FW, Koch G, Röcker L (1978) Die unterschiedliche Wirkung einer chronischen kardioselektiven und nicht kardioselektiven ß- Rezeptorenblockade auf den Plasma- katecholainspiegel während und nach standardisierter ergometrischer Leistung. Z Kardiol Suppl 5: 71Google Scholar
  158. 145.
    Franz I-W, Lohmann FW (1978) Die Bedeutung der ergometrischen Untersuchung zur Beurteilung der antihypertensiven Therapie. Dtsch Med Wschr 38: 1478Google Scholar
  159. 146.
    Franz I-W, Reinhart-Herdoiza (1978) Ergometry, physical training and hypertension. Kongreßband X XI. World Congress of Sports medicine, BrasiliaGoogle Scholar
  160. 147.
    Franz I-W, Lohmann FW (1979) Der Einfluß einer Saluretikum-β-Rezeptorenblocker-Kombination auf überhöhte Belastungsblutdrücke. Med Klin 74: 396PubMedGoogle Scholar
  161. 148.
    Franz I-W (1979) Untersuchungen über das Blutdruckverhalten während und nach Ergometrie bei Grenzwerthypertonikern im Vergleich zu Normalpersonen und Patienten mit stabiler Hypertonie. Z Kardiol 68: 107PubMedGoogle Scholar
  162. 149.
    Franz I-W, Lohmann FW (1979) Der Einfluß einer chronischen kardioselektiven und nichtselektiven ß-Rezeptorenblockade auf den Blutdruck, die 02-Aufnahme und den Kohlenhydratstoffwechsel. Z Kardiol 68: 503PubMedGoogle Scholar
  163. 150.
    Franz I-W (1979) Welchen Sport dürfen und sollen Hypertoniker betreiben? Med Trib 36: 27Google Scholar
  164. 151.
    Franz I-W (1979) Indikationen, Dosierung und Kontraindikationen präventiven Trainings. In: Mellerowicz H, Franz I-W (Hrsg) Training als Mittel der präventiven Medizin, S. 27, Perimed, ErlangenGoogle Scholar
  165. 152.
    Franz I-W, Lohmann FW, Koch G (1979) Vergleichende Untersuchungen über die Wirkung einer chronischen kardioselektiven und nicht kardioselektiven Rezeptorenblockade auf die Plasmareninaktivität und den Blutdruck vor, während und nach Ergometrie bei Hochdruckkranken. Therapiewoche 29: 7753Google Scholar
  166. 153.
    Franz I-W, Lohmann FW, Koch G (1980) Differential effects of long-term cardioselective and nonselective beta-receptor blockade on plasma catecholamines during and after physical exercise in hypertensive patients. J Cardiovasc Pharmacol 2: 35PubMedGoogle Scholar
  167. 154.
    Franz I-W (1980) Differential antihypertensive effect of acebutolol and the fixed combination hydrochlorothiazide/amiloridehydrochloride on elevated exercise blood pressures in hypertensive patients. Am J Cardiol 46: 301PubMedGoogle Scholar
  168. 155.
    Franz I-W, Lohmann FW, Koch G (1980) Excessive dopamine increase at rest and during exercise after long-term betaadrenoreceptor blockade in hypertensive patients. Br Heart J 44: 25PubMedGoogle Scholar
  169. 156.
    Franz I-W, Mellerowicz H (1980) Vergleichende ergometrische Untersuchungen über den Tension-Time-Index und die körperliche Leistungsbreite bei Patienten mit grenzwertiger und stabiler Hypertonie und Normalpersonen. Z Kardiol 69: 587PubMedGoogle Scholar
  170. 157.
    Franz I-W, Lohmann FW, Koch G, Agrawal B (1980) Der Einfluß einer chronischen β-Rezep- torenblockade auf den Kohlenhydrat- und Fettstoffwechsel und deren hormonale Regulation bei Hochdruckkranken. Verh Dtsch Ges Inn Med 86: 105Google Scholar
  171. 158.
    Franz I-W, Lohmann FW (1980) Unterschiedlicher Einfluß einer chronischen, überwiegend β1 selektiven und β1- β2-Rezeptorenblockade auf den Kohlenhydratstoffwechsel. Ergometrische Untersuchungen bei Hochdruckkranken. Klin Wschr 58: 1155Google Scholar
  172. 159.
    Franz I-W (1980) Die antihypertensive Wirksamkeit einer fixen β-Rezeptorenblocker-Diureti- kum-Kombination auf Ruhe- und Belastungsblutdruck von essentiellen Hypertonikern. Schw Med Wschr 110: 1616Google Scholar
  173. 160.
    Franz I-W, Lohmann FW (1980) The effect of β-blockers on metabolism during exercise. In: Roskamm H, Graefe KH (eds) Advances in Blocker Therapy. Amsterdam, Oxford, Princeton, Excerpta Medica 45–54Google Scholar
  174. 161.
    Franz I-W, Lohmann FW, Agrawal B (1981) Beeinflussung des Belastungsblutdruckes 2,8 und 24 Stunden nach Gabe pharmakologisch unterschiedlicher β-Rezeptorenblocker bei chronischer Behandlung. Verh Dtsch Ges Inn Med 87: 518Google Scholar
  175. 162.
    Franz I-W (1981) Einfluß einer fixen β-Rezeptorenblocker-Diuretika-Kombination auf den hohen Blutdruck im Alter. Ergometrische Untersuchungen über das Blutdruckverhalten und den myokardialen 02-Verbrauch. Herz/Kreislauf 4: 187Google Scholar
  176. 163.
    Franz I-W (1982) Ergebnisse eines Expertengespräches. In: Krebs R, Aumiller J (Hrsg) Beta- Blocker: Leitlinien für die Praxis. MMW-Medizin Verlag, MünchenGoogle Scholar
  177. 164.
    Franz I-W, Lohmann FW, Koch G (1982) Effects of chronic antihypertensive treatment with acebutolol and pindolol on blood pressure plasma catecholamines and oxygen uptake at rest an during submaximal and maximal exercise. J Cardiovasc Pharmacol 4: 180PubMedGoogle Scholar
  178. 165.
    Franz I-W (1982) Vergleichende ergometrische Untersuchungen über die Wirkung von β-Rezeptorenblockern und Diuretika und deren Kombination auf den Blutdruck und das Doppelprodukt bei Hochdruckkranken. Z Kardiol 71: 129PubMedGoogle Scholar
  179. 166.
    Franz I-W, Lohmann FW, Koch G (1982) Körperliche Leistungsfähigkeit und Plasmakate- cholamine während einer Kurz- und Langzeit-β-Rezeptorenblockade. Therapiewoche 46: 5730Google Scholar
  180. 167.
    Franz I-W, Lohmann FW (1982) Die Bedeutung ergometrischer Untersuchungen bei arterieller Hypertonie. Herz 7: 156PubMedGoogle Scholar
  181. 168.
    Franz I-W, Mellerowicz H (1982) Methodische und leistungsphysiologische Grundlagen der Ergometrie. Herz 7: 29PubMedGoogle Scholar
  182. 169.
    Franz I-W, Eismann D, Mellerowicz H (1983) Einfluß von Training und Gewichtsabnahme auf koronare Risikofaktoren. Kongreßband Dtsch Kongreß f Sportmed, Köln. Deutscher Ärzteverlag, S 283Google Scholar
  183. 170.
    Franz I-W, Quabbe H-J, Melier W, Mellerowicz H (1983) Lipolyse und Fettverbrennung und deren hormonelle Regulation bei Marathonläufern während einer Ausdauerbelastung. Kongreßband Dtsch Kongreß f Sportmed, Köln. Deutscher Ärzteverlag, S 283Google Scholar
  184. 171.
    Franz I-W, Koch G, Meiler W, Mellerowicz H (1984) Plasma catecholamines during steady- state exercise in marathon runners. Kongreßband XXII World Congress of Sports Medicine, Wien. Urban & Schwarzenberg, Wien, p 389Google Scholar
  185. 172.
    Franz I-W (1982) Ergometrie bei Hochdruckkranken. - Diagnostische und therapeutische Konsequenzen für die Praxis. Springer, Berlin Heidelberg New YorkGoogle Scholar
  186. 173.
    Franz I-W, Lohmann FW (1982) Reproduzierbarkeit des Blutdruckverhaltens während und nach Ergometrie bei Hochdruckkranken. Dtsch med Wschr 107: 1379PubMedGoogle Scholar
  187. 174.
    Franz I-W (1982) Welchen Stellenwert haben Sport und Bewegungstherapie im Therapiekonzept der Hypertonie? Sportmedizinische und präventive Aspekte. In: Matzdorff F, Nowacki PE (Hrsg) Tagungsbericht der Deutschen Gesellschaft für präventive und rehabilitative Kardiologie, Bad Nauheim. Perimed, ErlangenGoogle Scholar
  188. 175.
    Franz I-W (1982) Hypertonie und Sport. In: Rosenthal J (Hrsg) Arterielle Hypertonie. Springer, Berlin Heidelberg New York, zweite Auf!Google Scholar
  189. 176.
    Franz I-W (1983) Zur Wirkung des ai-Rezeptorenblockers Prazosin und des β-Rezeptorenblockers Acebutolol und deren Kombination auf den Blutdruck und das Doppelprodukt. Z Kardiol 72: 746Google Scholar
  190. 177.
    Franz I-W, Wiefel D (1984) Antihypertensive Wirkung von Calziumantagonisten auf Ruhe- und Belastungsblutdruck im Vergleich zu β-Rezeptorenblockern. 89. Tagung Dtsch Ges Innere Med, Wiesbaden. 89, S1138Google Scholar
  191. 178.
    Franz I-W (1983) Effect of acebutolol on elevated exercise blood pressure in hypertension. In: Lichtlen P, Maranhao M (Hrsg) 3rd International Beta Blocker Symposium Rio de Janeiro. Schattauer Verlag, Stuttgart, S147Google Scholar
  192. 179.
    Franz I-W (1983) Beeinflussung des Belastungsblutdruckes durch antihypertensive Pharmaka. In: Distler A, Philip T Neuere Entwicklungen in der Hochdrucktherapie. Schattauer, Stuttgart, S 71Google Scholar
  193. 180.
    Franz I-W, Lohmann FW, Röcker L (1984) Unterschiedlicher Einfluß einer chronischen β-selektiven und Rezeptorenblockade auf den Lipidstoffwechsel bei Hochdruckkranken. Herz/Kreislauf 3: 115–122Google Scholar
  194. 181.
    Franz I-W, Lohmann FW, Koch G, Quabbe H-J (1983) Aspects of hormonal regulation of lipolysis during exercise: effects of chronic ß-receptorblockade. Int J Sports Med 4Google Scholar
  195. 181a.
    Franz I-W, Wiewel D, Ketelhut R (1984) Antihypertensiver Effekt einer β-blockierend und vasodilatorisch wirkenden Substanz auf Ruhe- und Belastungsblutdruck im Vergleich zur al- leinigen β-Rezeptorenblockade. Verh Dtsch Ges Inn Med Bd90: 750Google Scholar
  196. 181b.
    Franz I-W, Ketelhut R, Behr U, Wiewel D (1985) Vergleichende Untersuchung zur Wirkung von Kalziumantagonisten und β-Rezeptorenblockern auf den Ruhe- und Belastungsblutdruck bei Hochdruckkranken. Klin Wsehr 63 (Suppl IV) 248Google Scholar
  197. 181c.
    Franz I-W, Wiewel D, Behr U, Ketelhut R (1986) Ruckbildung der Myokardhypertrophie Hochdruckkranker unter chronischer p-Rezeptorenblockade. DMW 14: 530–534Google Scholar
  198. 181d.
    Franz I-W, Behr U, Ketelhut R, Agrawal B (1986) Regression der Linksherzhypertrophie Hochdruckkranker durch Calziumantagonisten. Z Kardiol 75, Supple 1: 106Google Scholar
  199. 182.
    Freudenberg K (1962) GrundriB der medizinischen Statistik. Schattauer, StuttgartGoogle Scholar
  200. 183.
    Frick MH, Katila M (1968) Hemodynamic consequences of physical training after myocardial infarction. Circulation 37: 192Google Scholar
  201. 184.
    Frisch P (1978) HerzgroBe, Puis und Blutdruck in Ruhe unter Atenolol. Med Klin 73: 1477PubMedGoogle Scholar
  202. 185.
    Frisk-Holmberg M, Juhlin-Dannfelt A, Jorsfeldt L, Astrom H (1976) Effect of long-term antihypertensive p-receptorblocking treatment on hemodynamic and metabolic responses to prolonged exercise in man. Clin Sci Mol Med 51: 489Google Scholar
  203. 186.
    Frisk-Holmberg M, Jorsfeldt L, Juhlin-Dannfelt A, Karlsson J (1976) Effect of long-term beta- blocking treatment on muscle metabolism in hypertensive man. Acta Physiol Scand (suppl) 480: 90Google Scholar
  204. 187.
    Frisk-Holmberg M, Jorsfeldt L, Juhlin-Dannfelt A, Astrom A (1977) Influence of alprenolol on haemodynamic and metabolic responses to prolonged exercise in subjects with hypertension. Clin Pharmacol Ther 21: 675PubMedGoogle Scholar
  205. 188.
    Frisk-Holmberg M, Ostman J (1977) Differential inhibition of lipolysis in human adipose tissue by adrenergic beta-receptor blocking drugs. J Pharmacol Exp Ther 200: 598PubMedGoogle Scholar
  206. 189.
    Frisk-Holmberg M, Jorsfeldt L, Juhlin-Dannfelt A, Kralson J (1979) Metabolic changes in muscle on long-term alprenolol therapy. In: Clin Pharmacol Ther 26: 566Google Scholar
  207. 189a.
    Frohlich ED, Tarazi RC (1979) Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy. Amer J Cardiol 44: 459Google Scholar
  208. 190.
    Fuchs G (1980) Umgang mit statistischen Zahlenangaben bei der arztlichen Begutachtungs- praxis. Lebensversicherungsmedizin 5: 115Google Scholar
  209. 191.
    Furberg C (1967) Adrenergic beta-blockade and physical work capacity. Acta Med Scand 182: 119PubMedGoogle Scholar
  210. 192.
    Galbo H, Hoist JJ and Christensen NJ (1975) Glucagon and plasma catecholamine responses to exercise in trained rats. J Appl Physiol 38: 70PubMedGoogle Scholar
  211. 193.
    Galbo H, Hoist J J, Christensen NJ and Hilsted J (1976) Glucagon and plasma catecholamines during beta-receptor blockade in exercising man. J Appl Physiol 40: 855PubMedGoogle Scholar
  212. 194.
    Galbo H, Richter EA, Hoist J J and Christensen NJ (1977) Diminished hormonal responses to exercise in trained rats. J Appl Physiol 43: 953PubMedGoogle Scholar
  213. 195.
    Galbo H, Christensen NJ, Hoist J J (1977) GlucoScinduced decrease in glucagon and epinephrine response to exercise in man. J Appl Physiol 42: 525PubMedGoogle Scholar
  214. 196.
    Galbo H, Richter EA, Hilsted J, Hoist JJ, Christensen N, Henriksson J (1977) Hormonal regulation during prolonged exercise. Ann NY Acad Sci 301: 72PubMedGoogle Scholar
  215. 197.
    Galbo H, Houston ME, Christensen NJ et al (1979) The effect of water temperature on the hormonal response to swimming. Acta Physiol Scand 105: 326PubMedGoogle Scholar
  216. 198.
    Garber AJ, Cryer PE, Santiago JV, Haymond MW, Pagliara AS and Kipnis DM (1976) Role of adrenergic mechanism in substrate and hormonal response to insulin-induced hypoglycemia in man. J Clin Invest 58: 7PubMedGoogle Scholar
  217. 199.
    Gerich JE, Corenzi M, Bier DM, Tsalikian E, Schneider V, Karam JH, Forsham PH (1976) Effect of physiological levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. J Clin Invest 57: 875PubMedGoogle Scholar
  218. 200.
    Ghosh P, Cochrane AMG, de Bono D (1975) Effects of long-term practolol therapy on plasma-lipids after acute myocardial infarction. Lancet 1: 9PubMedGoogle Scholar
  219. 201.
    Gibson DG (1974) Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man. Drugs 7: 8PubMedGoogle Scholar
  220. 202.
    Glatzel H (1980) Fettleibigkeit und soziale Sitation. Med Welt 31: 355PubMedGoogle Scholar
  221. 203.
    Gluck Z, Weidmann P, Mordasini R, Peheim E, Bachmann L, Keusch G, Riesen W (1979) Einfluß einer Diuretikatherapie auf die Serumlipoproteine: ein unerwünschter Effekt. Schweiz Med Wschr 109: 104PubMedGoogle Scholar
  222. 204.
    Goldberg LI (1972) Cardiovascular and renal actions of dopamine: Potential clinical applications. Pharmacology Review 24: 1Google Scholar
  223. 205.
    Goldberg MB, Lisser H (1942) Acromegaly: A consideration of its course and treatment. The J Clin Endocrinol 2: 477Google Scholar
  224. 206.
    Goldstein JL, Hazzard WR, Schrolt HG, Biermann L, Motoulsky AG (1973) Hyperlipemia in coronaiy heart disease. J Clin Invest 52: 1553Google Scholar
  225. 207.
    Gollnick PD (1973) Factors controlling glycogenolysis and lipolysis during exercise. In: Keul J (Hrsg) Limiting factors of physical performance. Georg Thieme, Stuttgart, S 81Google Scholar
  226. 208.
    Goodman HM (1967) Effects of growth hormone on glucose utilization in diaphragma muscle in the absence of increated lipolysis. Endocrinology 81: 1099–1103PubMedGoogle Scholar
  227. 209.
    Gordon DA, Hill FM, Ezrin C (1962) Acromegaly: A revies of 100 cases. Canad Med Ass J 87: 1106PubMedGoogle Scholar
  228. 210.
    Gordon T, Calstelli WP, Hjostland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease. Am J Med 62: 707PubMedGoogle Scholar
  229. 211.
    Granath A, Jonsson B, Strandell T (1964) Circulation in healthy old men, studied by right heart catheterization at rest and during exercise in supine and sitting position. Acta Med Scand 176: 425PubMedGoogle Scholar
  230. 212.
    Greenblatt DJ, Koch-Weser J (1973) Adverse reaction to propranolol in hospitalized medical patients. A report from the Boston Collaborative Drug, Surveillance Program. Am Heart J 86: 478PubMedGoogle Scholar
  231. 213.
    Greenwood FC, Landon J (1966) Growth hormone secretion in response to stress in man. Nature 210: 540PubMedGoogle Scholar
  232. 214.
    Grimby G, Smith U (1978) β-blockade and muscle function. Lancet II: 1318Google Scholar
  233. 215.
    Grobecker H, Planz G, Wiethold G, Simsrock R, Becker HJ, Lutz E, Petersen P (1976) Specific and non-specific effects of ß-adreno-receptor blocking drugs in man. Klin Wschr 54: 783PubMedGoogle Scholar
  234. 216.
    Groop L, Töltermann KJ, Harno K, Gordin H (1983) Influence of beta-blocking drugs on glucose metabolism in hypertensive, non-diabetic patients. Acta Med Scand 213: 9PubMedGoogle Scholar
  235. 217.
    Groß F (1974) Drug therapy in hypertension. What we have, what we need, what we except. Am J Cardiol 34: 471PubMedGoogle Scholar
  236. 218.
    Groß F (1978) Klinische Pharmakologie der β-Adrenozeptoren Blocker. Internist 19: 504PubMedGoogle Scholar
  237. 219.
    Gross SR, Nayer SE (1974) Regulation of Phosphorylase B to A conversion in muscle. Life Sci 14: 401–14PubMedGoogle Scholar
  238. 220.
    Gugler R (1978) Therapie mit Beta-Rezeptorenblockern. Nebenwirkungen und Kontraindikationen. Internist 19: 547PubMedGoogle Scholar
  239. 221.
    Haggendahl LL, Hartley H and Saltin B (1970) Arterial noradrenaline concentration during exercise in relation to relative work levels. Scand J Clin Lab Invest 26: 337Google Scholar
  240. 222.
    Halhuber MJ (1966) Längsschnittuntersuchungen an Hochdruckkranken während einer Klima- und Terrainkur in 2000 m Höhe. Sportarzt und Sportmed 17: 473Google Scholar
  241. 223.
    Hansson BG, Hökfelt B (1975) Long-term treatment of moderate hypertension with pentubo- lol. Eur J Clin Pharmacol 9: 9PubMedGoogle Scholar
  242. 224.
    Hansson BG (1976) Long-term non-selective and cardio-selective receptor blockade in hypertensive patients. Acta Med Scand Suppl 598: 1PubMedGoogle Scholar
  243. 225.
    Hansson BG, Dymling JF, Hedeland H, Hulthen UL (1977) Long term treatment of moderate hypertension with the betarreceptor blocking agent metoprolol. Eur J Clin Pharmacol 239 und 247Google Scholar
  244. 226.
    Harms HH, Gooren L, Spoelstra AJ, Hesse C (1978) Blockade of isoprenaline-induced changes in plasma free fatty acids, immuno-reactive insulin levels and plasma renin activily in healthy human subjects by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol. Br J Clin Pharmac 5: 19Google Scholar
  245. 227.
    Harri MNB (1979) Physical training under the influence of beta-blockade in rats. II Effects on vascular reactivity. Eur J Appl Physiol 42: 151Google Scholar
  246. 228.
    Harris L, Dargie HJ, Lynch PG, Bulpitt J, Krikler DM (1982) Blood pressure and heart rate in patients with ischemic heart disease receiving infedipin and propranolol. Brit Med J 284: 1148Google Scholar
  247. 229.
    Harry JD, Knapp MF, Linden RJ, Stoker JB, Newcombe L (1979) Effects of 4 β-adrenoceptor-blocking drugs on blood pressure and exercise heart rate in hypertension. Eur J Cardiol 10: 131PubMedGoogle Scholar
  248. 230.
    Hartley LH, Mason JW, Hogan RP (1972) Multiple hormonal responses to graded exercise in relation to physical training. J Appl Physiol 33: 602PubMedGoogle Scholar
  249. 231.
    Hartley LH, Masin JW, Hogan RP (1972) Multiple hormonal responses to prolonged exercise in relation to physical training. J Appl Physiol 33: 607PubMedGoogle Scholar
  250. 232.
    Hartling OJ, Noer I, Svendsen TL, Clausen JP and Trap-Jensen J (1980) Selective and non-selective beta-adrenoceptor blockade in the human forearm. Clin Sci 58: 279PubMedGoogle Scholar
  251. 233.
    Hasselbach HC, Beck K, Eskildsen PC (1981) Serum prolactin and thyrotrop in responses to thyrotropin-releasing-hormone in men with alcoholic cirrhosis. Acta Med Scand 209: 37Google Scholar
  252. 234.
    Hauss WH (1982) Zur Pathogenese der Arteriosklerose. Med Welt 33: 20PubMedGoogle Scholar
  253. 235.
    Havel JR, Carlson LA, Ekelund L-G, Holmgren A (1973) Turnover rate and oxidation of different free fatty acids in man during exercise. J Appl Physiol 19: 613Google Scholar
  254. 236.
    Helmreich EJM (1976) Hormone-receptor interactions FEBS. Letters 61: 1Google Scholar
  255. 237.
    Herberg L, Berger M, Gries FA (1974) Comparative investigations on lipolysis and reesterification in adipose tissue of man and various species of mice. Comp Biochem Physiol (A) 48: 163Google Scholar
  256. 238.
    Hessler JR, Robertson AL, Chrisholm GM III (1979) LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 32: 213PubMedGoogle Scholar
  257. 239.
    Heyden S (1974) Ergebnisse und Konsequenzen der Post-Framingham-Studie. Risikofaktoren für das Herz. MannheimGoogle Scholar
  258. 240.
    Hickson RG, Rennie MJ, Conlee RK (1977) Effects of increased plasma free fatty acids on glycogen utilization and endurance. J Appl Physiol 43: 829PubMedGoogle Scholar
  259. 241.
    Hilsted J, Galbo H, Christensen NJ (1980) Impaired responses of catecholamines, growth hormone and Cortisol to graded exercise in diabetic autonomic neuropathy. Diabetes 29: 257PubMedGoogle Scholar
  260. 242.
    Hirth-Schmidt H, Raptis S, Schröder KE, Pfeifer EF (1973) Die Wirkung der Beta-Rezeptoren- blocker Pindolol (LB 46) und Beta-Adrenol (KL 255) auf die durch Argenin und Muskelarbeit induzierte Wachstumshormonsekretion beim Menschen. In: Beringer H (Hrsg) 3. Internationales Donau-Symposium. Mandrich, Wien München Bern, S 781Google Scholar
  261. 243.
    Hochdruck-Ratgeber: Sport und Bewegung. Bayer AG, Pharma Wiss AbteilungGoogle Scholar
  262. 244.
    Hodge JV, Smirk FH (1967) The effect of drug treatment of hypertension on the distribution of deaths from various causes. Am Heart J 73Google Scholar
  263. 245.
    Holland OB, Nixon JV, Kuhnert L (1981) Diuretic-induced ventricular ectopic activity. Amer J Med 70: 762PubMedGoogle Scholar
  264. 246.
    Hollmann W, Barg W, Weyer G, Heck H (1970) Der AlterScinfluß auf spiroergometrische Meßgrößen im submaximalen Arbeitsbereich. Med Welt 21: 1280Google Scholar
  265. 247.
    Hollmann W (1974) Leistungsphysiologische Grundlagen zur rehabilitativen Kardiologie. In: Mellerowicz H, Weidener J, Jokl E (Hrsg) Rehabilitative Kardiologie, S. 44. Karger, BaselGoogle Scholar
  266. 248.
    Holm G, Herlitz J, Smith U (1981) Severe hypoglycaemia during physical exercise and treatment with beta-blockers. Brit Med J 282: 1360Google Scholar
  267. 249.
    Holloszy JO, Mole PA, Baldwin KM, Teijung RL (1973) Exercise induced enzymatic adaptations in muscle. Keul J (Hrsg) In: Limiting factors of physical performance. Georg Thieme, Stuttgart, S 66Google Scholar
  268. 250.
    Holmgren A (1956) Circulatory changes during mucular work in man. With special reference to arterial and central venous pressures in the systematic circulation. Scand J Clin Lab Invest 8, Suppl 24: 1PubMedGoogle Scholar
  269. 251.
    Hornung RS, Gould BA, Kieso HA, Raftery EB (1981) The effect of Modueren on 24 hour blood monitoring. Abstract, Symposium: Potassium, the Heart and Hypertension, RomeGoogle Scholar
  270. 252.
    Hultmann EL, Nilsson L (1974) Liver glycogen as a glucose-supplying source during exercise. In: Keul J (Hrsg) Limiting factors of physical performance, S. 179. Thieme, StuttgartGoogle Scholar
  271. 253.
    Hunter WM, Fonseka CC, Passmore R (1965) Growth hormone: important role in muscular exercise in adults. Science 150: 1051PubMedGoogle Scholar
  272. 254.
    Hypertension Detection and Follow-up Program Cooperative Groups (1979) Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction on mortality of persons with high blood pressure including mild hypertension. J Am Med Ass 242: 2562Google Scholar
  273. 255.
    Hypertension Detection and Follow-up Program Cooperative Group (1979) Five-year follow- up Program. II. Mortality by race, sex and age. J Am Med Ass 242: 2572Google Scholar
  274. 255a.
    Ibrahim MM, Madkour MA, Mossallam R (1980) Effect of atenolol on left ventricular function in hypertensive patients. Circulation 62: 1036PubMedGoogle Scholar
  275. 255b.
    Ibrahim MM, Madkour MA, Mossallam R (1981) Factors influencing cardiac hypertrophy in hypertensive patients. Clin Sci 61: 105Google Scholar
  276. 256.
    Ireland MA, Littler WA (1981) The effects of oral acebutolol and propranolol on forearm blood flow in hypertensive patients. Br J Clin Pharmae 12: 363Google Scholar
  277. 257.
    Irving MH, Britton BJ, Wood WG, Padgham C, Carruthers M (1974) Effects of adrenergic blockade in plasma catecholamines in exercise. Nature 248: 531PubMedGoogle Scholar
  278. 258.
    Isbary J, Greding H, Nechwatal W, König B (1978) Hämodynamische Veränderungen bei Hypertonikern nach Sympathikolyse mit Propranolol und Metoprolol. Z Kardiol 67: 857PubMedGoogle Scholar
  279. 259.
    Issekutz B (1978) Role of beta-adrenergic receptors in mobilization of energy sources in exercising dogs. J Appl Physiol 44: 869–876PubMedGoogle Scholar
  280. 260.
    Jahnecke J (1974) Risikofaktor Hypertonie. MannheimGoogle Scholar
  281. 261.
    Jakob AF (1977) Energiestoffwechsel und Regulation des hepatischen Glykogen-Umsatzes durch Hormone. Fortschr Med 95: 1923–1926PubMedGoogle Scholar
  282. 262.
    Johnson W, Grover J (1967) Hemodynamic and metabolic effects of physical training in four patients with essential hypertension. Canad Med Ass J 96: 842PubMedGoogle Scholar
  283. 263.
    Johnsson G (1975) Influence of metoprolol and propranolol on hemodynamic effects induced by adrenaline and physical work. Acta Pharmacol Toxicol 36 (Suppl V): 59Google Scholar
  284. 264.
    Jokl E, Ball M, Frankel L (1967) Ergometry, exercise and hypertension. In: Mellerowicz H, Hansen G (Hrsg) 2. Int Seminar für Ergometrie. ErgonGoogle Scholar
  285. 265.
    Jörgensen CR, Wang K, Gobel FL (1974) Effect of propranolol on myocardial oxygen consumption during static and dynamic exercise. Circulation 50: 1179PubMedGoogle Scholar
  286. 266.
    Jürgensen HJ, Meinertz H, Faergeman O (1982) Plasma lipids and lipoproteins in long-term beta-adrenergic blockade. Acta Med Scand 211: 449PubMedGoogle Scholar
  287. 267.
    Julius S, Pascual AV, Sannerstedt R (1971) Relationship between cardiac output and peripheral resistance in borderline hypertension. Circulation 43: 382PubMedGoogle Scholar
  288. 268.
    Juhlin-Dannfelt A, Frisk-Homberg M, Karlsson J, Tesch P (1979) Central and peripheral circulation in relation to muscle fibre composition in normo- and hypertensive man. Clin Sci 56: 335PubMedGoogle Scholar
  289. 269.
    Juhlin-Dannfelt A (1982) Metabolic effects of ß-adrenoreceptor blockade on skeletat muscle at rest and during exercise. Acta Med Scand (Suppl 66 ): 113Google Scholar
  290. 270.
    Juhlin-Dannfelt A (1983) β-adrenoceptor blockade and exercise: effects on endurance and physical training. Acta Med Scand (suppl 672): 49Google Scholar
  291. 271.
    Junges FL, Ball EG (1963) Studies on the metabolism of adipose tissue. XII. The effects of insulin and epinephrine on free fatty acid and glycerol production in the presence and absence of glucose. Biochemistry 2: 383Google Scholar
  292. 272.
    Kaiser P, Rössner S, Karlsson J (1981) Effect of β-adrenergic blockade on endurance and short-time performance in respect to individual muscle fibre composition. Int J Sports Med 2: 37PubMedGoogle Scholar
  293. 273.
    Kannel WB, Widmer LK, Dawber TR (1965) Gefährdung durch coronare Herzkrankheit. Folgerungen für die Praxis aus 10 Jahren Framigham-Studie. Schweiz Med Wschr 95: 18PubMedGoogle Scholar
  294. 274.
    Kannel WB, Gordon T, Schwartz MJ (1971) Systolic versus diastolic blood pressure and risk of coronary disease. Am J Cardiol 27: 335PubMedGoogle Scholar
  295. 275.
    Kannel WB, Castelli WP, Gordon T (1979) Cholesterol in the prediction of artherosclerotic disease. Ann Intern Med 90: 85PubMedGoogle Scholar
  296. 275a.
    Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M (1972) Role of blood pressure in the development of congestive heart failure. N Engl J Med 287: 781PubMedGoogle Scholar
  297. 276.
    Karlsson J, Bonde-Petersen F, Henriksson J, Knuttgen HG (1975) Effects of previous exercise with arms or legs on metabolism and performance in exhaustive exercise. J Appl Physiol 38: 763PubMedGoogle Scholar
  298. 276a.
    Kaul M, Mohan JC, Bhatia M (1984) Effects of labetalol on left ventricular mass and function in hypertension. - An assessment by serial echocardiography. Int J Cardiol 5: 461PubMedGoogle Scholar
  299. 276b.
    Kathri J, Gottdiener J, Notargiacomo A, Freis E (1980) Effect of therapy on left ventricular function in hypertension. Clin Sci 59: 436Google Scholar
  300. 277.
    Kellermann JI, Ben-Ari E, Chaquet M, Lapidot C, Drory Y, Fisman E (1977) Cardiocirculatory response to different typs of training in patients with angina pectoris. Cardiology 62: 218PubMedGoogle Scholar
  301. 278.
    Keul J, Haralambie G (1971) Die chronischen Effekte des körperlichen Trainings auf den Stoffwechsel. Verh Dtsch Ges Kreisl-Forsch 37: 101Google Scholar
  302. 279.
    Keul J, Huber G, Kindermann W, Burmeister P, Petersen KG (1976) Die Wirkung eines neuartigen β-Rezeptorenblockers ( Bunitrilol) auf Kreislauf und Stoffwechsel unter extremen Streßbedingungen. Med Welt 27: 437PubMedGoogle Scholar
  303. 280.
    Keul J, Huber G, Maas A, Blessing W, Westermann H, König K (1976) Der Einfluß des ß- Blockers Bunitrol auf metabolische, hormonelle und kardiozirkulatorische Veränderungen bei Herzkranken während des Fernsehens. In: Herz/Kreisl 8: 578Google Scholar
  304. 281.
    Kiesewetter R (1982) Ergebnisse der Spiroergooxytensiometrie vor und nach antihypertensiver Behandlung. Med u Sport 22: 168Google Scholar
  305. 282.
    Kilpatrick JA (1978) The variaton of casual, basal, and supplemental blood pressure in health and in essential hypertension. Br Heart J10: 48Google Scholar
  306. 283.
    Kindermann W, Schmitt WM, Biro G, Schnabel A (1981) Metabolismus und hormonelles Verhalten bei Körperarbeit unter akuter Betar Sympathikolyse. Z Kardiol 70: 406PubMedGoogle Scholar
  307. 284.
    Kissebah AH (1974) Stress hormones and lipid metabolism. Proc R Soc Med 67: 665PubMedGoogle Scholar
  308. 285.
    Kitamura K, Jörgensen CR, Göbel F (1972) Hemodynamic correlates of myocardial oxygen consumption during upright exercise. J Appl Physiol 32: 516PubMedGoogle Scholar
  309. 286.
    Klein W, Mlekusi E, Härringer M (1982) Kalziumantagonisten zur Behandlung der chronischen arteriellen Hypertonie. Herz/Kreisl 5: 247Google Scholar
  310. 287.
    Klose G, Grefen H (1980) Schützt HDL-Cholesterin vor Herzinfarkt? Med Klin 75: 67PubMedGoogle Scholar
  311. 288.
    Knauf H (1969) Die Wirkung der Betarezeptorenhemmstoffe auf die Durchblutung des arbeitenden Skelettmuskels. Z Kreislaufforsch 58: 749PubMedGoogle Scholar
  312. 289.
    Koch G (1977) Plasma renin activity, epinephrine and norephephrine at rest and during exercise in young adults and boys. Scand J Clin Lab Invest Suppl 147: 37, 107Google Scholar
  313. 290.
    Koch G (1978) Plasma catecholamines and plasma renin activity during submaximal and near- maximal exercise in normotensive adolescents and adults, and in hypertensive patients. (Abstr) Fifth Scientific Meeting of the International Society of Hypertension, S140Google Scholar
  314. 291.
    Koch G, Johansson U, Arvidsson E (1980) Determination of epinephrine, norepinephrine and dopamine in 0,1 ml plasma samples. J Clin Chem Clin Biochem 18: 367PubMedGoogle Scholar
  315. 292.
    Koch G, Franz I-W, Gubba A, Lohmann FW (1983) β-adrenoceptor blockade and physical activity: cardiovascular and metabolic aspects. Acta Med Scand (suppl 672 ): 55Google Scholar
  316. 293.
    Kölendorf K, Bonnevie-Nielsen V, Broch-Möller B (1982) A trial of metoprolol in hypertensive insulindependent diabetic patients. Acta Med Scand 211: 175PubMedGoogle Scholar
  317. 294.
    König K, Gebhardt W, Ulimann HW, Reindell H (1968) Veränderungen des Herzvolumens sowie einiger wichtiger spiroergometrischer Parameter nach β-Rezeptorenblockade. Z Kreisl- Forschg 57: 415Google Scholar
  318. 295.
    König K, Ruck H, Brusis O (1977) Der Effekt körperlichen Trainings im Rahmen der Frührehabilitation nach Herzinfarkt. Herz/Kreisl 4: 192Google Scholar
  319. 296.
    Koerker DJ, Goodner CJ, Toivola PTK, Gale CC and Ensink JW (1974) Adaption to fasting in baboon. I. Influence of feeding schedule. Am J Physiol 227: 520PubMedGoogle Scholar
  320. 297.
    Koerker DJ, Goodner CD, Chideckel EW and Ensink JW (1975) Adaption to fasting in baboon. II. Regulation of lipolysis early and late in fasting. Am J Physiol 229: 350Google Scholar
  321. 298.
    Koivisto VA, Karonen S-L, Nikkilä EA (1981) Carbohydrate ingestion before exercise: comparison of glucose, fructose and sweet placebo. J Appl Physiol 51: 783PubMedGoogle Scholar
  322. 299.
    Kolloch R, Stumpe KO, Higuchi M, Vetter H, Krück F (1977) Erhöhte Plasma-Prolactin-Konzentration bei essentieller Hypertension: Index einer verminderten hypothamalischen dop- aminergen Aktivität. Klin Wschr 55: 20, 1013PubMedGoogle Scholar
  323. 300.
    Kolloch R, Myers M, Bornheiner J, de Quattro V (1981) Hämodynamik und Katecholamine während statischer Muskelarbeit bei essentieller Hypertonie. Einfluß kombinierter a- und ß- Rezeptorenblockade. 87. Verh Dtsch Ges Inn MedGoogle Scholar
  324. 301.
    Kotler MN, Bermann L, Rubinstein AH (1966) Hypoglycaemia precipitaded by Propranolol. Lancet 1: 1389Google Scholar
  325. 302.
    Krönig B (1976) Blutdruckvariabilität bei Hochdruckkranken. Hüthig, HeidelbergGoogle Scholar
  326. 303.
    Kumana CR, Marlin GE, Kaye CM and Smith DM (1974) New approach to assessment of cardioselectivity of beta-blocking drugs. Br Med J 4: 444PubMedGoogle Scholar
  327. 304.
    Lager I, Blohme G, Smidt U (1979) Effect of cardioselective and nonselective β-blockade on the hypoglycaemic response in insulin-dependent diabetics. Lancet 3: 458Google Scholar
  328. 305.
    Lake CR, Ziegler MG, Kopin IJ (1976) Use of plasma norepinephrine for evaluation of sympathetic neurologic function in man. Life Sci 18: 1315PubMedGoogle Scholar
  329. 306.
    Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG (1967) Differention of receptor systems activated by sympathomimetic amines. Nature 214: 597PubMedGoogle Scholar
  330. 307.
    Leary WP (1974) The cardioselectivity of acebutolol in man. Clin Trials J11: 33Google Scholar
  331. 308.
    Leenen FHH, Coener CHM, Zondersland M, Maas AHJ (1980) Effects of cardioselective and nonselective β-blockade in dynamic exercise performance in mildly hypertensive men. Clin Pharmacol Ther 28: 12PubMedGoogle Scholar
  332. 309.
    Lehmann M, Keul J, Löllgen H, Just H (1981) Plasmakatecholamine und Hämodynamik bei gestörter linksventrikulärer Funktion in Ruhe und bei Belastung. Z Kardiol 70: 238PubMedGoogle Scholar
  333. 310.
    Lehmann M, Keul J, Wybitul K (1980) Belastungsabhängige Veränderungen der Plasmakatecholamine unter Bunitrolol und Methypranol. Beeinflussung von Lipolyse- und Glycogenolyse.Z Kardiol 9: 242Google Scholar
  334. 311.
    Lehmann M, Keul J, Wybitul K, Fischer H (1982) Auswirkung einer selektiven und nicht selektiven Adrenozeptorenblockade während Körperarbeit auf den Energiestoffwechsel und das sympathoadrenerge System. Arzneim-Forsch 32: 261Google Scholar
  335. 312.
    Lehtonen A, Viikari J (1979) Longterm effects of soltalol on serum lipids. Clin Sci 57: 405sGoogle Scholar
  336. 313.
    Leitch AG, Hopkin JM, Ellis DA, McClarkson G, Merchant S and McHardy GJR (1980) Failure of propranolol and metoprolol to alter ventilatory responses to carbon dioxide and exercise. Br J Clin Pharmacol 9: 493PubMedGoogle Scholar
  337. 314.
    Leren P, Helgeland A, Holme J, Foss PO, Hjerman I, Lund-Larsen PG (1980) Effects of propranolol and prazosin on blood lipids. The Oslo Study. Lancet 2: 4Google Scholar
  338. 315.
    Lerner RL, Porte D (1971) Epinephrine: Selective inhibition of the acute insulin response to glucose. J Clin invest 50: 2453PubMedGoogle Scholar
  339. 316.
    Lie JT, Grossman SJ (1980) Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am Heart J100: 41Google Scholar
  340. 317.
    Liesen H (1974) Körperliches Training und Beta-Rezeptorenblockade. In: Mellerowicz H, Weidener J, Jokl E (Hrsg) Rehabilitative Kardiologie. BaselGoogle Scholar
  341. 318.
    Lindström L, Magnusson R, Petersen I (1979) Muscular fatigue and action potential conduction velocity changes studies with frequency analysis of EMG signals. Electromyogr 4: 341Google Scholar
  342. 319.
    Littler WA, Honour AJ, Pugsley DJ, Sleight P (1975) Continous recording of direct arterial pressure in untreated patients: its role in the diagnosis and management of high blood pressure. Circulation 51: 1101PubMedGoogle Scholar
  343. 320.
    Lloyd-Mostyn RH, Oram S (1975) Modification by propranolol of cardiovascular effects of induced hypoglycaemia. Lancet 1: 1213–1215PubMedGoogle Scholar
  344. 321.
    Lloyd-Mostyn RH, Lefevre D, Lord PS, Doig E, Krikler DM (1981) The effect of beta-adrenergic blocking agents on serum lipids. Atherosclerosis 14: 283Google Scholar
  345. 322.
    Lockwood RH, Lum BKB (1974) Effects of adrenergic agonists and antagonists on potassium metabolism. J Pharmacol Exp Ther 189: 119PubMedGoogle Scholar
  346. 323.
    Lohmann FW (1981) Die Beeinflussung des Stoffwechsels durch Beta-Rezeptoren-Blocker. Klin Wschr59: 49Google Scholar
  347. 324.
    Lohmann FW (Hrsg) (1982) β-Rezeptorenblockade. SpringerGoogle Scholar
  348. 325.
    Lorimer AR, Barbour MP, Comerfield MB, Lawrie DV (1982) Assessment of blood pressure responses in hypertension to isometric and varying form of dynamic exercise, and their modification by treatment. Abstract Ninth Scientific meeting of the International Society of Hypertension. Mexico City, p 252Google Scholar
  349. 326.
    Loubatieres A, Mariani MM, Sorel G, Savi L (1971) The action of β-adrenergic blocking and stimulating agents of insulin secretion. Characterization of the type of β-receptor. Diabetologia 7: 127PubMedGoogle Scholar
  350. 327.
    Lüderitz B (1978) Beta-Rezeptorenblocker bei kardialen Rhythmusstörungen. Internist 19: 532PubMedGoogle Scholar
  351. 328.
    Lundborg P, Aström H, Bengtsson C, Fellenius E, v Schenk H, Svensson L, Smith U (1981) Effect of β-adrenoceptor blockade on exercise performance and metabolism. Clinical Science 61: 299PubMedGoogle Scholar
  352. 329.
    Lund-Johansen P (1967) Hemodynamics in early essential hypertension. Acta Med Scand 183, Suppl 482: 1Google Scholar
  353. 330.
    Lund-Johansen P, Ohm OI (1976) Hemodynamic long-term effects of β-receptor blocking agents in hypertension: Comparison between alprenolol, atenolol and timolol. Clin Sci Mol Med 51: 481Google Scholar
  354. 331.
    Lund-Johansen P (1976) Hemodynamic effects of Clonidine in man. In: Onesti G, Fernandes M, Kim KE (Hrsg) Regulation of blood pressure by the central nervous system. Grune u Stratton, New YorkGoogle Scholar
  355. 332.
    Lund-Johansen P (1979) Hemodynamic consequences of long-term beta-blocker therapy: a 5 year follow-up study of atenolol. J Cardiovasc Pharmacol 1: 487PubMedGoogle Scholar
  356. 333.
    Lund-Johansen P (1980) Hämodynamik bei der essentiellen Hypertonie in Ruhe und während Ergometrie und deren Beeinflussung durch Diuretika, β-Rezeptorenblocker und Vasodilatatoren. In: Franz I-W (Hrsg) Belastungsblutdruck bei Hochdruckkranken. Springer, Berlin Heidelberg New York, S107Google Scholar
  357. 334.
    Lundvall J, Järhult J (1976) Beta-adrenergic dilator component of the symathetic vascular response in skeletal muscle. Acta Physiol Scand 96: 180PubMedGoogle Scholar
  358. 335.
    Lydtin H Welcher Sport ist für den Hypertoniker empfehlenswert? Sandoz-Reihe: Experten beantworten Fragen zur HypertonieGoogle Scholar
  359. 336.
    Mäurer W, Schöming A, Kaden F, Dietz R (1978) Effect of propranolol and bunitrolol on symathic activity. Verh Dtsch Ges Inn Med 84: 468Google Scholar
  360. 337.
    Maksud MG, Tristani FE, Coolls KO, Barboriak JJ, Hamilton LH (1970) Effect of propranolol on several physiological responses during orthostatic and exercise stress in healthy male subjects. Can J Physiol Pharmacol 49: 867Google Scholar
  361. 338.
    Malek I, Waagstein F, Hjalmarson A, Holmberg S (1978) Hemodynamic effects of the cardio- selective β-blocking agent metoprolol in acute myocardial infarction. Acta Med Scand 204: 195PubMedGoogle Scholar
  362. 339.
    Management Comittee (1980) The Australian therapeutic trial in mild hypertension. Lancet 10: 1261Google Scholar
  363. 340.
    Mann S, Millar-Crong MW, Altmann DG, Melville D, Raftery EB (1979) The effects of metoprolol and ambulatory blood pressure. Clin Science 57: 375sGoogle Scholar
  364. 341.
    Matthes D, Schütz P, Hüllemann K-D (1978) Unterschiede zwischen indirekt und direkt ermittelten Blutdruckwerten. Med Klin 11: 371Google Scholar
  365. 342.
    Mayer S, Moran NC, Fain J (1961) The effect of adrenergic blocking agents on some metabolic actions of catecholamines. J Pharmacol Exp Hier 134: 18Google Scholar
  366. 343.
    McAllister RG (1979) Effects of adrenergic receptor blockade on the responses to ergometrie handgrip: Studies in normal and hypertensive subjects. J Cardiovasc Pharmacol 1: 253PubMedGoogle Scholar
  367. 344.
    McDonald RH Jr, Goldberg LI, McNay JL and Tuttle EP Jr (1964) Effect of dopamine in man. Argumentation of sodium excretion, glomerular filtration rate and renal plasma flow. J Clin Invest 43: 1116PubMedGoogle Scholar
  368. 345.
    McFate Smith W (1977) Treatment of mild hypertension. Results of a ten-year intervention trial. Circ Res 40, Suppl I: 1Google Scholar
  369. 346.
    McSorley PD and Warren DJ (1978) Effects of propranolol and metoprolol on the peripheral circulation. Br Med J 2: 1598 - 1600PubMedGoogle Scholar
  370. 347.
    Mellerowicz H (1956) Vergleichende Untersuchungen über das Ökonomieprinzip in Arbeit und Leistung des trainierten Kreislaufs und Scine Bedeutung für die präventive und rehabilitative Medizin. Arch Kreisl Forsch 24: 70Google Scholar
  371. 348.
    Mellerowicz H (1979) Ergometrie. 3. neubearb Aufl. Urban & Schwarzenberg, München Wien BaltimoreGoogle Scholar
  372. 349.
    Merimce TJ, Rabin O (1973) A survey of growth hormone secretion and action. Metab Clin Exp 22: 1235Google Scholar
  373. 350.
    Merker R, Schwittek W, Kladetzky R-G, Kuhn H (1981) Serumlipide unter chronischer Behandlung mit β-Rezeptorenblockern bei Patienten mit Herzkrankheit. Z Kardio 70: 455Google Scholar
  374. 351.
    Mertz DP (1980) Atherosklerose-Index (LDL/HDL): Risikoindikator bei Störungen des Fettstoffwechsels. Med Klin 75: 159PubMedGoogle Scholar
  375. 351a.
    Messerli FH, Ventura HO, Glade LB, Sundgaard-Rüse K, Dunn FG, Fröhlich E (1983) Essential hypertension in the elderly: haemodynamics intravascular volume, plasma reninactivity, and circulating catecholamine levels. Lancet II: 983Google Scholar
  376. 352.
    Metropolitan Life Insurance Company (1961) Blood pressure: Insurance experience and its implications. New YorkGoogle Scholar
  377. 353.
    Miall WE, Bell RA, Lovell HG (1968) Relation between changes in blood pressure and weight. Br J Prev Soc Med 22: 73PubMedGoogle Scholar
  378. 354.
    Middecke M, Burkhart A, Holzgreve H (1982) Blutdruckverhalten während dynamischer und isometrischer Belastungen unter antihypertensiver Langzeittherapie mit Beta- Rezeptorenblokkern und Diuretika. 88. Verh Dtsch Ges Inn Med 737Google Scholar
  379. 355.
    Miettinen T, Huttmann JK, Ehnholm C, Kumlin T, Mattila S, Naukkarinen V (1980) Effect of long-term antihypertensive and hypolipidemic treatment on high density lipoprotein cholesterol and apoliproteins A-I and A-II. Atherosclerosis 36: 249PubMedGoogle Scholar
  380. 356.
    Molé PA, Oscai LB, Holloszy JO (1971) Adaptation of muscle to exercise. Increase in the levels of palmityl CoA synthetase, caraitic palmityl-transferase, and palmityl CoA dehydrogenase, and in the capacity to oxidize fatty acids. J Clin Invest 50: 2323PubMedGoogle Scholar
  381. 357.
    Moratinos J, Potter DE, Ellis S (1975) The influence of propranolol on catecholamine. Induced changes in carbohydrate metabolism in the rabbit. Eur J Pharmacol 32: 186PubMedGoogle Scholar
  382. 358.
    Mordasini R, Glück Z, Weichmann P, Keusch G, Meyer A, Riesen W (1980) Zur Pathogenese der Diuretika-induzierten Hyperlipoproteinämie. Klin Wschr 58: 359PubMedGoogle Scholar
  383. 359.
    Morgan T, Adam W, Carney S, Gibbard R, Brown S, Wheeler D (1979) Treatment of mild hypertension in elderly males. Clin Sci 75: 355sGoogle Scholar
  384. 360.
    Morganti A, Pickering TG, Lopez-Ovejero JA, Laragh JH (1979) Contrasting effects of acute betablockade with propranolol on plasma catecholamines and renin in essential hypertension. Am Heart J 98: 490PubMedGoogle Scholar
  385. 361.
    Morgenroth J, Maron BJ, Henry WL, Epstein SE (1975) Comparative left ventricular dimension in trained athlets. Am Intern Med 82: 521Google Scholar
  386. 362.
    Mortimer JT, Magnusson R, Petersen K (1970) Conduction velocity in ischemic muscle: Effect on EMG frequency spectrum. Am J Physiol 219: 1324–1329PubMedGoogle Scholar
  387. 363.
    Moser L, Schmidt M, Lundt PV (1979) Die Wirkungen eines Beta-Rezeptorenblockers auf die Kraftfahreigenschaft. Med Klin74: 1134Google Scholar
  388. 364.
    Muir GG, Chamberlain DA, Tunstall Pedoe D (1964) Effects of β-sympathetic blockade on non-esterifled-fatty-acid and carbohydrate metabolism at rest and during exercise. Lancet 10: 930–932Google Scholar
  389. 365.
    Nakamura Y, Schwartz A (1972) The influence of hydrogen ion concentration on calcium binding and release by skeletal muscle-sacroplasmic reticulum. J Gen Physiol 59: 22Google Scholar
  390. 365a.
    Nakashima J, Fouad F, Tarazi R(1984) Regression of left ventricular hypertrophy from systemic hypertensive by enalapril. Amer J Cardiol 53: 1044PubMedGoogle Scholar
  391. 366.
    Nelson RR, Gobel FL, Jörgensen CR (1973) Hemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise. Circulation 50: 1173Google Scholar
  392. 367.
    Nerem RM, Cornhill JF (1980) Hemodynamics and atherogenesis. Atherosclerosis 36: 151PubMedGoogle Scholar
  393. 368.
    Nilsson A, Hansson B-G, Hokfelt B (1978) Effect of metoprolol on blood glycerol, free fatty acids, triglycerides and glucose in relation to plasma catecholamines in hypertensive patients at rest and following submaximal exercise. Europ J Clin Pharmacol 13: 5Google Scholar
  394. 369.
    Nyberg G (1976) Effect of ß-adrenoreceptor blockers on heart rate and blood pressure in dynamic and isometric exercise. Drugs 11 (Suppl 1): 185PubMedGoogle Scholar
  395. 369a.
    Opie LH (1980) Drugs and the Heart. III.Calcium antagonists. Lancet 2: 806–810Google Scholar
  396. 370.
    Palm D (1977) Adrenerge β-Rezeptoren und β-Rezeptorenblocker. In: Hierholzer K, Rietbrock N (Hrsg) Perimed, ErlangenGoogle Scholar
  397. 371.
    Patrick JM and Pearson SB (1980) Beta-adrenoceptor blockade and ventilation in man (Letter). Br J Clin Pharmacol 10: 624–625PubMedGoogle Scholar
  398. 372.
    Patyna WD (1981) Die Beeinflussung des Blutdruckverhaltens Hochdruckkranker während Ergometrie durch eine Reserpin-Diuretikum-Kombination und β-Rezeptorenblocker. In: Franz I-W (Hrsg) Belastungsblutdruck bei Hochdruckkranken. Springer, Berlin Heidelberg New York, S139Google Scholar
  399. 373.
    Pearson SB, Banks DC and Patrick JM (1979) The effect of beta-adrenoceptor blockade on factors affecting exercise tolerance in normal man. Br J Clin Pharmacol 8: 143PubMedGoogle Scholar
  400. 374.
    Pedersen EB, Christensen NJ (1975) Catecholamines in plasma and urine in patients with essential hypertension, determined by double isotope derivative techniques. Acta Med Scandl 98: 373Google Scholar
  401. 375.
    Pernow B, Saltin B (1971) Availability of substrates and capacity for prolonged heavy exercise in man. J Appl Physiol 31: 416PubMedGoogle Scholar
  402. 376.
    Philipp Th, Cordes U, Distler A (1977) Sympathetic responsiveness and antihypertensive effect of betareceptor blockade in essential hypertension. Dtsch Med Wschr 102: 569PubMedGoogle Scholar
  403. 377.
    Philipp Th, Distler A (1979) Gefaßreagibilität unter Diuretika. Med Welt 26: 1015Google Scholar
  404. 378.
    Pickering TG, Harshfield GA, Kleinen HD, Blank S, Laragh JH (1982) Blood pressure during normal daily activities, sleep and exercise. JAMA 247: 992PubMedGoogle Scholar
  405. 378a.
    Pietro DA (1981) Reproducibility of echocardiography. Chest 79: 29PubMedGoogle Scholar
  406. 379.
    Pinter EJ and Pattee CP (1967) Effect of β-adrenergic blockade on resting and stimulated fat mobilization. J Clin Endocrinol 27: 1441Google Scholar
  407. 380.
    Pirnay F, Lacroix M, Mosora F, Luyckx A, Lefebore R (1977) Effect of glucose ingestion on energy substrate utilization during prolonged muscular exercise. Eur J Appl Physiol 36: 247Google Scholar
  408. 381.
    Planz G, Planz R (1981) Dissociation between duration of plasma catecholamine and blood pressure responses to beta-adrenergic blockade in normotensive subjects during physical exercise. Europ Clin Pharmacol 14: 83Google Scholar
  409. 382.
    Pluoin PF, Comoy E, Bohuon C, Corvol P, Menard J (1979) Activité rénine et noradrénaline plasmatiques au cours du traitement antihypertenseur par l’acébutolol. Nouv Presse Med 8: 1905Google Scholar
  410. 383.
    Ponari O, Civardi E, Poti R (1972) Action of some betablockers on plasma fibrinolysis in vitro and in vivo in man. Arzneim Forsch 22: 629Google Scholar
  411. 384.
    Porte D, Williams Jr RH (1966) Inhibition of insulin release by norepinephrine in man. Science 152: 1248PubMedGoogle Scholar
  412. 385.
    Powers SP, Howley ET, Cox R (1982) A differential catecholamine response during prolonged exercise and passive heating. Med Sci Sports Exercise 14: 435Google Scholar
  413. 386.
    Prachar H, Heller G, Jobst Ch, Kiss E, Nobis H, Spiel R, Enenkel W (1976) Zum koronaren Risiko bei Hypertonikern. Herz/Kreis 18: 174Google Scholar
  414. 387.
    Prichard BNC (1964) Hypotensive action of pronethalol. Br Med J1: 1227Google Scholar
  415. 388.
    Pristantz H, Pavek P, Klein W (1977) Die Rolle der Serumtriglyceride als koronarer Risikofaktor. ZKardiol 66: 216Google Scholar
  416. 389.
    Pruett ED, Maehlum S (1973) Muscular exercise and metabolism in male juvenile diabetics. Energy metabolism during exercise. Scand J Clin Lab Invest 32: 139PubMedGoogle Scholar
  417. 390.
    Putzeys MR, Hoobler SW (1972) Comparison of Clonidin and methyldopa on blood pressure and side effects in hypertensive patients. Am Heart J 83: 464PubMedGoogle Scholar
  418. 391.
    Quabbe H-J (1969) Radioimmunologische Bestimmung von Wachstumshormon im Plasma des Menschen. Z Klin Chem Klin Biochem 7: 259PubMedGoogle Scholar
  419. 392.
    Quabbe H-J, Ramek W, Luyckx AS (1977) Growth hormone, glucagon and insulin response to depression of plasma free fatty acids and the effect of glucose infusion. J Clin Endocrinol Metab 44: 383–391PubMedGoogle Scholar
  420. 393.
    Raben MS, Hollenberg CH (1959) Effect of growth hormone on plasma fatty acids. J Clin Invest 38: 484PubMedGoogle Scholar
  421. 394.
    Rahn KH, Hawlina A, Kersting F, Planz G (1974) Studies on the antihypertensive action of the optical isomers of propranolol in man. Naunyn-Schmiedeberg’s Arch Pharmacol 286: 319PubMedGoogle Scholar
  422. 395.
    Raine HE, Pickering TG (1977) Cardiovascular and sympathetic response to exercise after long-term beta-adrenergic blockade. Brit Med J 2: 90PubMedGoogle Scholar
  423. 396.
    Ramdohr B, Biamino G, Schüren KP, Schröder R (1975) Dopamin bei der Behandlung der akuten schweren Herzinsuffizienz. Med Welt 26: 540PubMedGoogle Scholar
  424. 397.
    Rändle P, Garland PB, Hales NC (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785PubMedGoogle Scholar
  425. 398.
    Rasmussen S, Rasmussen K (1979) Influence of metoprolol alone and in combination with a thiazid diuretic, on blood pressure, plasma volume, extracellular volume and glomerular filtration rate in essential hypertension. Eur J Clin Pharmacol 15: 305PubMedGoogle Scholar
  426. 399.
    Reindell H, König K, Roskamm H (1967) Funktionsdiagnostik des gesunden und kranken Herzens. Schattauer, StuttgartGoogle Scholar
  427. 400.
    Reisin E, Abel R, Modan M, Silverberg DS, Eiahon HE, Modan B (1978) Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. New Engl Med 298: 1Google Scholar
  428. 401.
    Relman AS (1980) Mild hypertension: no more benign neglect. New Engl J Med 302: 293PubMedGoogle Scholar
  429. 402.
    Rennie MJ, Winder HW, Holloszy JO (1976) A sparing effect of increased plasma fatty acids on muscle and liver glycogen content in the exercising rat. Biochem J156: 647Google Scholar
  430. 403.
    Reuben SR (1981) Comparative effects if two antihypertensive drugs on blood pressure and heart rate response during ergometrie exercise. Abstract, Symposium, Potassium, The Heart and Hypertension. RomeGoogle Scholar
  431. 404.
    Reybrouck T, Amery A, Billiet L (1977) Hemodynamic response to graded exercise after chronic beta-adrenergic blockade. J Appl Physiol 42: 133PubMedGoogle Scholar
  432. 405.
    Rhoads GG, Guldbrandsen ChL, Kagan A (1976) Serum lipoproteins and coronary heart disease. New Engl J Med 294Google Scholar
  433. 406.
    Ricci DR, Orlick AE, Cipriano PR, Guthauer DF, Harrison DC (1979) Altered adrenergic activity in coronary arterial spasm: Insight into mechanism based in study of coronary hemodynamics and the electrocardiogramm. Am J Cardiol 43: 1073PubMedGoogle Scholar
  434. 407.
    Richter EA, Galbo H, Christensen NJ (1981) Control of exercise-induced muscular glycogenosis by adrenal medullary hormones in rats. J Appl Physiol 50: 21PubMedGoogle Scholar
  435. 408.
    Richter EA, Ruderman NB, Gavras H, Belur ER, Galbo H (1982) Muscle glycogenolysis during exercise: dual control by epinephrine and contractions. Am J Physiol 242: E 25Google Scholar
  436. 409.
    Rieckert H, Kattwinkel W, Riechelmann H, Kuß A, Sieran R (1981) Gefaßreaktionen der unteren Extremitäten auf eine akute Betablockade in Ruhe und bei körperlicher Belastung. Med Welt 24: 967Google Scholar
  437. 410.
    Rifkind BM, Tamir I, Heiss G, Wallace RB, Tyroler HA (1979) Distribution of high density and other lipoproteins in selected LRC, prevalence study populations: A brief survey. Lipids 14: 105PubMedGoogle Scholar
  438. 411.
    Rizza RA, Cryer PE, Gerich JE (1979) Role of glucagon, catecholamines and growth hormone in human glucose counter regulation. J Clin Invest 64: 62PubMedGoogle Scholar
  439. 411a.
    Roberts WC (1975) The hypertensive diseases. Evidence that systemic hypertension is a greater risk factor to the development of other cardiovascular diseases than previously suspected. Amer J Med 59: 523PubMedGoogle Scholar
  440. 412.
    Robertson RP, Porte D (1973) Adrenergic modulation of basal insulin secretion in man. Diabetes 22: 1PubMedGoogle Scholar
  441. 413.
    Robertson SP, Kessich WGL (1979) The effect of PH on Ca+ + activated force in dog skeletal muscle fibres. Pfügers Arch 380: 41Google Scholar
  442. 414.
    Röcker L (1977) Der Einfluß körperlicher Aktivität auf das Blut. In: Hollmann W (Hrsg) Zentrale Themen der Sportmedizin. Springer, Berlin Heidelberg New York, S 91Google Scholar
  443. 415.
    Rost R, Hollmann W, Liesen H (1976) Körperliches Training mit Hochdruckpatienten, Ziele und Probleme. Herz/Kreisl 2: 680Google Scholar
  444. 416.
    Rost R (1979) Kreislaufreaktion und -adaptation unter körperlicher Belastung. Osang, BonnGoogle Scholar
  445. 417.
    Rost R, Hollmann W (1982) Belastungsuntersuchungen in der Praxis. Thieme, StuttgartGoogle Scholar
  446. 418.
    Rowlands DB, Irland MA, Stallard TJ, Glover TR, McLeay AB, Watson RDS, Littler WA (1982) Assessment of left ventricular mass and its response to antihypertensive treatment. Lancet II: 467Google Scholar
  447. 419.
    Roth J, Glick GM, Yalow RS, Berson SA (1963) Hypoglycaemia: a powerful stimulus to secretion of growth hormone. Science 140: 987PubMedGoogle Scholar
  448. 420.
    Sacca L, Sherwin R, Hendler R, Felig P (1976) Influence of continious physiologic hyperinsulinemia on glucose kinetics and counter-regulatory hormones in normal and diabetic humans. J Clin Invest 58: 7Google Scholar
  449. 420a.
    Sahn DJ, de Maria A, Kisslo J, Weyman A (1977) The Committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072Google Scholar
  450. 421.
    Sannerstedt R, Julius S (1972) Systemic hemodynamics in borderline arterial hypertension: Response to static exercise before and under the influence of propranolol. Cardiovasc Res 6: 398Google Scholar
  451. 422.
    Sarnoff S, Case JRB, Stainsky WN, Macruz R (1958) Hemodynamic determinants of oxygen consumption of the heart with special reference to the tensiontime-index. Am J Physiol 192: 148PubMedGoogle Scholar
  452. 423.
    Schade DS, Woodside W, Eaton RP (1979) The role of glucagon in the regulation of plasma lipids. Metabolism 28: 874PubMedGoogle Scholar
  453. 424.
    Schalch DS, Kipnis DM (1965) Abnormalities in carbohydrate tolerance associated with elevated plasma nonesterified fatty acids. J Clin Invest 44: 2010Google Scholar
  454. 425.
    Schettler G (1979) Ist der Kampf gegen die Herz- und Gefäßkrankheiten zu gewinnen? Z Allg Med 55: 667Google Scholar
  455. 426.
    Schimert E (1965) Körperbelastung und Koronarerkrankungen. Münch Med Wschr 18: 894Google Scholar
  456. 427.
    Schnelle K, Schinz A, Klein G, Fenze E, Radespeck A (1978) Klinisch-pharmakologische Befunde zur Differentialtherapie mit Beta-Rezeptoren-Blockern. Autoreferateband 5. Herbsttagung Dtsch Ges Kreisl Forsch Z Kardiol Suppl 5: 70Google Scholar
  457. 428.
    Schoknecht G, Thefeld W, Hoffmeister H (1980) Bluthochdruck, Übergewicht und Hypercho- lesterinämie: unabhängige Faktoren? Med Welt 31: 588PubMedGoogle Scholar
  458. 429.
    Schönig A, Dietz R, Kaden F, Luth JB, Maurer W (1977) Sympathischer Gefaßtonus bei ß- Blockade. Autoreferate 43. Jahrestag Dtsch Ges für Kreislaufforschung, S. 12Google Scholar
  459. 430.
    Scholhamer C, Feiig P, Hendler R-G (1971) Propranolol hypoglycemia: increases peripheral effectiveness of insulin. Clin Res 19: 736Google Scholar
  460. 431.
    Schulte W (1980) Blutdruckreaktivität unter emotionalem Streß bei essentieller Hypertonie - pathologische und diagnostische Aspekte. In: Franz I-W (Hrsg) Belastungsblutdruck bei Hochdruckkranken. Springer, Berlin Heidelberg New York, S 59Google Scholar
  461. 432.
    Scow RQ, Chernick SS (1970) Mobilization, transport and utilization of free fatty acids. Comp Biocheml8: 19Google Scholar
  462. 432a.
    Sen S, Tarazi RC, Khairallah PA, Bumpus FMM (1974) Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res 35: 775PubMedGoogle Scholar
  463. 432b.
    Sen S, Tarazi RC (1983) Regression of myocardial hypertrophy and influence of adrenergiv system. Amer J Physiol 13: 97Google Scholar
  464. 433.
    Scipel L, Breithardt G, Döhring HP (1977) Die Wirkung von Atenolol auf den Sinusknoten und die intrakardiale Erregungsleitung beim Menschen im Vergleich zu Propranolol. Z Kardiol 66: 719Google Scholar
  465. 434.
    Shaw J, England JD, Hua ASD (1978) Betablocker and plasma triglycerides. Br Med J1: 986Google Scholar
  466. 435.
    Shaw DB, Holman RR, Gowers JI (1980) Survival in sinoatrial disorder. Br Med J 1: 139Google Scholar
  467. 436.
    Shephard J, Packard J, Patsch R, Gotto jr AM, Taunton OD (1979) Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein metabolism. J Clin Invest 63: 858Google Scholar
  468. 437.
    Simon G, Dickhut HH, Windscheidt U, Kindermann W, Keul J (1979) Hämodynamische und metabolische Auswirkungen der Betarezeptorenblockade durch Metipranolol. Herz/ Kreisl 11: 134Google Scholar
  469. 438.
    Sivertson R, Andersson O, Hansson L (1979) Blood pressure reduction and vascular adaption. Acta Med Scand205: 477Google Scholar
  470. 438a.
    Smith D, Odel H, Kernohan JW (1950) Causes of death in hypertension. Amer J Med 9: 516PubMedGoogle Scholar
  471. 439.
    Smith U (1983) Adrenergic control of lipid metabolism. Acta Med Scand (Suppl 672 ): 41Google Scholar
  472. 440.
    Smithen CS, Balcon R, Sowton E (1971) Use of his potentials to assess changes in atrioventricular conduction produced by a series of beta-adrenergic blocking agents. Br Heart J 33: 995Google Scholar
  473. 440a.
    Sokolow M, Perloff D (1961) The prognosis of essential hypertension treated conservatively. Circulation 23: 697Google Scholar
  474. 441.
    Sokolow M, Perloff D, Cowan R (1982) A 10-year prospective study of the incidence of cardiovascular events in hypertensive patients utilizing ambulatory blood pressure measurements. Abstract, Ninth Scientific Meeting of the International Society of Hypertension, Mexico CityGoogle Scholar
  475. 442.
    Soman VR (1979) Increased insulin binding to monozytes after physical training. New Engl J Med 301: 1200PubMedGoogle Scholar
  476. 443.
    Stamler J, Schoenberger JA, Schekelle RB, Stamler R (1974) Hypertension. The problem and the challenge. In: Merck, Sharp & Dohme The hypertension handbook. Merck & Co West Point, Pa 19486Google Scholar
  477. 444.
    Stamler JSt, Farinario E, Mojounier LM, Haie Y, Moss D, Stamler R (1980) Prevention and control of hypertension by nutritional-hygienic means. J Am Med Ass 18: 1819Google Scholar
  478. 445.
    Stankiewics-Chroszucha B, Gorski J (1978) Effect of decreased availability of substrates on intramuscular triglyceride utilization during exercise. Eur J Appl Physiol 40: 27Google Scholar
  479. 446.
    Stanton HC (1972) Selective metabolic and cardio-vascular betareceptor antagonism in the rat. Arch Int Pharmacodyn 196: 246PubMedGoogle Scholar
  480. 447.
    Stegemann J, Kenner T (1974) A theory on heart control by muscular metabolic receptors. Arch Kreisl-Forsch 64: 185Google Scholar
  481. 448.
    Steinbrunn W, Klappenberger L, Lichtlen PR (1981) Die Häufigkeit des plötzlichen Herztodes bei der koronaren Herzkrankheit. Schweiz Med Wschr 111: 1697PubMedGoogle Scholar
  482. 449.
    Stephens J A, Taylor A (1972) Fatigue of maintained voluntary muscle contraction in man. J Physiol (Lond) 220: 1Google Scholar
  483. 450.
    Stoker JB, Sreeharan N, Linden RJ, Barbour MP, Lorimer AR, Hillis WS, Lawrie TDV (1979) The effects of exercise in hypertension controlled with metoprolol or methyldopa. Clin Sci 57: 391sGoogle Scholar
  484. 451.
    Strauer BE (1979) Das Hochdruckherz. Springer, Berlin Heidelberg New YorkGoogle Scholar
  485. 451a.
    Strauer BR, Mahmoud M, Bayer F, Bohn J, Motz M (1984) Reversal of left ventricular hypertrophy and improvement of cardiac function in man by nifedipine. Europ Heart J 5 (Suppl 7) 53Google Scholar
  486. 452.
    Strauss HC, Gilbert M, Svenson RH, Miller HC, Wallace AG (1976) Electrophysiological effects of propranolol on sinus node function in patients with sinus node dysfunction. Circulation 54: 452PubMedGoogle Scholar
  487. 453.
    Streja D, Mymin D (1978) Effect of propranolol on HDL-Cholesterol concentrations. Br Med J 2: 1495PubMedGoogle Scholar
  488. 454.
    Stull JT, Mayer SE (1971) Regulation of phosphorylase activation in skeletal muscle in vivo. J Biol Chem 246: 5716PubMedGoogle Scholar
  489. 455.
    Sturm A, Schuster P (1977) Rehabilitation bei Hypertonic. Dtsch Med Wschr 102: 1732PubMedGoogle Scholar
  490. 456.
    Svardsudd K, Berglund G, Tibblin G (1976) Morbidity and mortality in treated and untreated hypertension: results from the Goteborg 50-year-old men study. Drugs (Suppl) 1: 34Google Scholar
  491. 456a.
    Svardsudd K, Tibblin G (1979) Mortality and morbidity during 13.5 years follow-up in relation to blood pressure. The study of men born in 1913. Acta Med Scand 205: 483PubMedGoogle Scholar
  492. 457.
    Swedberg K, Hjalmarson A, Holmberg S (1979) Effects of work and acute beta-receptor blockade on myocardial noradrenaline release in congestive cardiomyopathy. Clin Cardiol 2: 423Google Scholar
  493. 458.
    Tarazi RC, Dustan HP (1972) Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. Am J Cardiol 29: 633Google Scholar
  494. 458a.
    Tarazi RC, Cevi MN (1982) Cardiac response to increased afterload: state of the review. Hypertension 4 (Suppl 1 ) II: 8PubMedGoogle Scholar
  495. 458b.
    Tarazi RC, Sen S, Fouad FM, Wicker R (1983) Regression of myocardial hypertrophy: conditions and sequelae of reversal in hypertensive heart disease. In: Alpert NR (ed) Perspectives in Cardiovascular Research, vol 7. Myocardial Hypertrophy and Failure. New York Raven Press, 637Google Scholar
  496. 458c.
    Tarazi RC, Gifford R (1983) Left ventricular hypertrophy and hypertension. JAMA 250: 1319PubMedGoogle Scholar
  497. 459.
    Tanaka N, Sagaguchi S, Oshige K, Niimura T, Kanehsia T (1976) Effect of chronic administration of propranolol on lipoprotein composition. Metabolism 25: 1071PubMedGoogle Scholar
  498. 460.
    Taylor SH (1975) The circulation in hypertension. In: Burley DM, Birdwood GFB, Fryer JH, Taylor SH Hypertension - its nature and treatment. Metropolis press, London, p 29Google Scholar
  499. 461.
    Tesch P (1980) Muscle fatique in man with special reference to lactate accumulation during short term intense exercise. Acta Physiol Scand (Suppl): 480Google Scholar
  500. 462.
    Thadani U, Parker JO (1979) Propranolol in angina pectoris. Duration of inproved exercise tolerance and circulatory effects after acute oral administration. Am J Cardiol 44: 118Google Scholar
  501. 463.
    The Coronary Drug Project (1972) Findings leading to further modifications of its products with respect to dextrothyrotrine. J Amer Med Ass 220: 996Google Scholar
  502. 464.
    Tibblin G, Wilhelmsen L, Werko L (1975) Risk factors for myocardial infarction and death due to ischemic heart disease and other causes. Am J Cardiol 35: 514PubMedGoogle Scholar
  503. 464a.
    Tomanek RJ (1982) Selective effects of a-methyldopa on myocardial cell components independent of cell size in normotensive and genetically hypertensive rats. Hypertension 4: 449Google Scholar
  504. 464b.
    Toshima H, Koga Y, Yoshioka H (1975) Echocardiographic classification of hypertensive heart disease. A correlation study with clinical features. Jpn Heart J16: 377Google Scholar
  505. 465.
    Trap-Jensen J, Clausen JP, Noer J, Larsen CA, Krogsgaard AR, Christensen NJ (1976) The effect of beta-adrenoceptor blockers on cardiac output, liver blood flow and skeletal muscle blood flow in hypertensive patients. Acta Physiol Scand (Suppl) 440: 31Google Scholar
  506. 466.
    Trap-Jensen J, Clausen JP, Noer J, Krogsgaard AR (1979) Effects of long-term beta-receptor blockade with propranolol on splanchnic-hepatic blood-flow and substrate exchange at rest and during exercise in hypertensive patients. Scand J Clin Lab Invest 39: 27Google Scholar
  507. 467.
    Turner GG, Nelson RR, Nordstrom LA, Diefenthal HC, Gobel FL (1978) Comperative effect of nadolol and propranolol on exercise tolerance in patients with angina pectoris. Br Heart J12: 1361Google Scholar
  508. 468.
    Twentyman OP, Dislay A, Gribbin HR, Alberti KG, Tattersfield AE (1981) Effect of β-adrenergic blockade on respiratory and metabolic responses to exercise. J Appl Physiol 51: 788PubMedGoogle Scholar
  509. 469.
    United States Public Health Service Hospitals (1972) Morbidity and mortality in mild essential hypertension. Circulat Res, Suppl II 30 and 31: 110Google Scholar
  510. 470.
    Uusitupa M, Aro A & Pietikainen M (1980) Severe hypoglycaemia caused by physical strain and pindolol therapy. Annals of Clinical Research 12: 25–27PubMedGoogle Scholar
  511. 471.
    Vanhees L, Fagard R, Amery A (1981) Influence of endurance training in patients with ischemic heart disease treated with beta–adrenergic blocking agents. Abstract II. World Congress on Cardiac Rehabilitation. Jerusalem, p 101Google Scholar
  512. 472.
    Van Herwaarden CLA, Fennis JFM, Binkhorst A, van’t Laar A: Hemodynamic effects of adrenaline during treatment of hypertensive patients with propranolol and metoprolol. Eur J Clin Pharmacol 12: 397Google Scholar
  513. 473.
    Van Herwaarden CLA, Binkhorst RA, Fennis JFM, van’t Laar A (1979) Effects of propranolol and metoprolol on haemodynamic and respiratory indices and on percieved exertion during exercise in hypertensive patients. Br Heart J 41: 99PubMedGoogle Scholar
  514. 474.
    Van Zwieten PA, Timmermanns PB (1979) Comparisons between the acute hemodynamic effects and brain penetration of acebutolol and metoprolol. J Cardiovasc Pharmacol 1: 85PubMedGoogle Scholar
  515. 475.
    Vatner SF, Braunwald E (1975) Cardiovascular control mechanism in the conscious state. New Engl J Med 293: 970PubMedGoogle Scholar
  516. 476.
    Vaughan M, Steinberg D (1963) Effect of hormones on lipolysis and esteriflcation of free fatty acids during incubation of adipose tissue in vitro. J Lipid Res 4: 193PubMedGoogle Scholar
  517. 477.
    Vedin A, Wilhelmson C, Werkö L (1975) Chronic alprenolol treatment of patients with acute myocardial infarction after discharge from hospital. Acta Med Scand Suppl 575: 7Google Scholar
  518. 478.
    Vendsalu A (1960) Studies on adrenaline and noradrenaline in human plasma. Acta Physiol Scand (Suppl) 173, 49: 1Google Scholar
  519. 479.
    Vereinbarungen des Standardisierungskomitees für Ergometrie im ICSPE (1967) Leistungsumsatzbedingungen bei ergometrischen Untersuchungen. In: Mellerowicz H, Hansen G (Hrsg) 2. Internationales Seminar für Ergometrie, S. 314. Ergon, BerlinGoogle Scholar
  520. 480.
    Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressure averaging 115 through 129 mmHg. J Am Med Ass 202: 1028Google Scholar
  521. 481.
    Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. J Am Med Ass 213: 1143Google Scholar
  522. 482.
    Veterans Administration Cooperative Study Group on Antihypertensive Agents (1972) Effects of treatment on morbidity in hypertension. Ill Influence of age, diastolic pressure and prior- cardiovascular disease; further analysis of side effects. Circulation 45: 991Google Scholar
  523. 483.
    Veterans Administration Cooperative Study Group on Antihypertensive Agents (1975) Effects of treatment on morbidity in hypertension. Circulation 51: 1107Google Scholar
  524. 484.
    Vick RL, Todd EP, Luedke DW (1972) Exercise-induced hyperkalemia: Effect of adrenergic β-receptor antagonism. Cardiovasc Res Center Bull 10: 84Google Scholar
  525. 485.
    Viru A, Smirnova T, Tomson K, Matsin T (1979) Dynamics of blood levels of pituitary hormones during prolonged exercise. Abstract International Symposium Biochemistry on Exercise. BrüsselGoogle Scholar
  526. 486.
    Vizi F, Pagatsa S, Kaldor A (1965) On sympathetic regulation of carbohydrate metabolism in the liver. J Pharm Pharmacol 17: 805PubMedGoogle Scholar
  527. 487.
    Vranic M, Kawamori R, Pek S, Kovacevic N and Wrenshall GA (1976) The essentiality of insulin and the role of glucagon on regulating glucose utilization and production during strenuous exercise in dogs. J Clin Invest 57: 245–255PubMedGoogle Scholar
  528. 488.
    Waagstein F, Hjalmarson A, Varnauskas B, Wallentin I (1975) Effects of chronic beta-adrenergic receptor blockade in congestive cardiomyopathie. Br Heart J 37: 1022PubMedGoogle Scholar
  529. 489.
    Waal-Manning HJ (1976) Metabolic effects of beta-adrenoceptor blockers. Drugs (Suppl) 1: 121Google Scholar
  530. 490.
    Wahren J (1977) Glucose turnover during exercise in man. Ann NY Acad Sci 301: 45PubMedGoogle Scholar
  531. 491.
    Walter J, Kircher St, Dölle H, Dietz A (1977) Die Muskeldurchblutung unter Orciprenalin- Stimulation und Beta-Sympathikolyse mit Propranolol sowie Metoprolol. Herz/Kreisl 10: 576Google Scholar
  532. 492.
    Watson RDS, Stallard TJ, Littler WA (1979) Influence once-daily administration of β-adrenoceptor antagonists on arterial pressure and its variability. Lancet 6: 1210Google Scholar
  533. 493.
    Wang P, Clausen T (1976) Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol. Lancet 1: 221PubMedGoogle Scholar
  534. 494.
    Weber E, Gundert-Remy U, Schrey A (1977) Patienten Compliance. Witzstrock, Baden-BadenGoogle Scholar
  535. 495.
    Weidener J, Mellerowicz H (1970) Dosiertes Training bei hypertonen Kreislaufregulationsstörungen. Internist 287Google Scholar
  536. 496.
    Weidmann P, Glück Z (1979) Grenzwert-Hypertonie. Schweiz Med Wschr 109: 417PubMedGoogle Scholar
  537. 497.
    Williams P, Robinson D, Bailey A (1979) Highdensity lipoprotein and coronary risk factors in normal men. Lancet I: 72Google Scholar
  538. 498.
    William-Olsson T, Fellenius I, Smith U, Björntorp P (1979) Differences in metabolic responses to β-adrenergic stimulation after propranolol or metoprolol administration. Acta Med Scand 205: 201PubMedGoogle Scholar
  539. 499.
    Wilson PW, Garrison RJ, Castelli WP, Feinleib M, McNamara PM, Kannel WB (1980) Prevalence of coronary heart disease in the Framingham Offspring Study: Role of lipoprotein cholesterols. Amer J Cardiol 46: 649Google Scholar
  540. 500.
    Winder WW, Hagberg JM, Hickson RC, Ehsani AA and McLane JA (1979) Time course of sympathoadrenal adaptation to endurance exercise training in man. J Appl Physiol 45: 370–374Google Scholar
  541. 501.
    Winder WW, Hickson RC, Hagberg JM, Ehsani AA and McLane JA (1979) Training induced changes in hormonal metabolic responses to submaximal exercise. J Appl Physiol 46: 766–771PubMedGoogle Scholar
  542. 502.
    Winer N, Mason WD, Carter CH, Willonghby TL, Kochak GM, Cohen I, Bell S (1979) Effects of atenolol on blood pressure, heart rate, renin, and norepinephrine during exercise. Clin Pharmacol Ther26: 315Google Scholar
  543. 503.
    Wirth A, Neermann G, Eckert W, Henck CC and Weicker H (1979) Metabolic response to heavy physical exercise before and after a 3-month training period. Eur J Appl Physiol 41: 51Google Scholar
  544. 504.
    Wirtzfeld A, Klein G, Delius W, Sack D (1978) Behandlung des akuten Myokardinfarktes mit Metoprolol. Dtsch Med Wschr 103: 566PubMedGoogle Scholar
  545. 505.
    Wolff G (1978) Bluthochdruck - die Pest unserer Zeit. Moderne Medizin 2: 87Google Scholar
  546. 506.
    Wolfram G, Schlierf G (1979) LDL-Cholesterin und HDL-Cholesterin - Risikofaktor und Schutzfaktor? Internist 20: 613PubMedGoogle Scholar
  547. 506a.
    Wong M, Shah PM, Taylor RD (1981) Reproducibility of left ventricular internal dimension with M-mode echocardiography: effects of heart size, body position and transducer angulation. Amer J Cardiol 47: 1068PubMedGoogle Scholar
  548. 507.
    World Health Organization (1959) Hypertension and coronary heart disease: classification and criteria for epidemological studies. Technical Report series No 168Google Scholar
  549. 508.
    World Health Organization (1962) Arterial hypertension and ischaemic heart disease. Technical Report series No 231Google Scholar
  550. 509.
    Yamaguchi N, De Champlain J, Nadeau RA (1977) Regulation of norepinephrine, release from cardiac sympathetic fibers in the dog by presynaptic alpha and beta receptors. Circ Res 41: 108–17PubMedGoogle Scholar
  551. 509a.
    Yamori Y, Tarazi RC, Ooshima A (1980) Effect of betablockers on cardiovascular structural changes in spontaneous and induced hypertension. VII. Congress Internat Soc Hypertension, New Orleans, 13Google Scholar
  552. 510.
    Zerzawy R, Bachmann K, Fleischer H (1976) Telemetrische Untersuchungen der Herz- und Kreislaufbelastung auf einem Trimmpfad. Dtsch Med Wschr 17: 664Google Scholar
  553. 511.
    Zerzawy R, Reis A, Bachmann K (1977) Belastungshypertonie bei Hochdruckkranken und Grenzwerthypertonikern. Autoreferateband 43, Jahrestagung Dtsch Ges Kreislaufforsch 112Google Scholar
  554. 512.
    Zerzawy R (1980) Telemetrie von arteriellem Druck und Herzfrequenz unter alltäglichen und sportlichen Belastungen im Vergleich zur Fahrradergometrie. In: Franz I-W (Hrsg) Belastungsblutdruck bei Hochdruckkranken. Springer, Berlin Heidelberg New York, S161Google Scholar
  555. 513.
    Zierler KL (1976) Fatty acids as substrates for heart and skeletal muscle. Circ Res 38: 459PubMedGoogle Scholar
  556. 514.
    Zilker Th, Schnelle K, Klein G, Schniz A, Fenzl F, Radlspeck A, Bottermann P (1978) Kohlenhydrat- und Fettstoffwechselwirkungen von Alprenolol und Metoprolol unter betaadrenerger Stimulation mit Isoproterenol am Stoffwechselgesunden. Verh Dtsch Ges Inn Med 84: 1163PubMedGoogle Scholar
  557. 515.
    Zinman B, Murray FT, Vranic M, Albisser M, Leibel BS, McLean PA and Marliss EB (1979) Glucoregulation during moderate exercise. Diabetes 28, Suppl 1: 82Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • Ingomar-Werner Franz
    • 1
  1. 1.Klinik Wehrawald der BfATodtmoos/SchwarzwaldGermany

Personalised recommendations